Interventive Gerontology 1.0.02: First, Try to Make it to the Mean: Diet as a life extending tool, Part 3

The Adventist Health Studies

Figure 1: Survival of California Adventist men (1980-1988) and other California men (1985) beyond the age of 30 years. The difference between the 2 groups was significant (P,.001). These were non-Hispanic white subjects. Hazards for 1989 are used for non-Adventist Californians older than 94 years (see the “Subjects and Methods” section of the text). AHS indicates Adventist Health Study; CI, confidence interval.

The Seventh-day Adventist Church (SDA) is a Christian denomination that was founded in 1963 as an offshoot of the Millerite movement in the US during the middle part of the 19th century. Ellen White, the principal founder of SDA, advocated a lifestyle incorporating the following five behaviors: not smoking, eating a plant based diet, eating nuts several times per week, engaging in regular exercise and maintaining normal body weight throughout the individual’s lifetime[1] Adventists also typically eschew alcohol (~8% drink), tobacco (~1.8% smoke), butter, strong seasonings (including pepper), caffeine (coffee, tea, cola) and consider the eating of pork, shellfish, and other foods proscribed as “unclean” in Leviticus as especially unwholesome.[2]

Beginning in 1960, two studies were conducted to determine the effects of the SDA lifestyle on all-cause mortality, as well as on disease-specific mortality and morbidity. The first study was conducted in the interval from 1960 to 1965. The Adventist Mortality Study, also known as the Adventist Health Study-1 (AHS-1) was comprised of 22,940 California Adventists and consisted of an intensive 5-year follow-up, and a more informal 25-year follow-up.[3] The AHS-1 found that the mean lifespan for California Adventist men was 6.2 years longer than for non-Adventist California men. The mean lifespan extension achieved by SDA women was more modest; a 3.7-year advantage over their non-SDA counterparts. These statistics were based on life table analyses.[4]

The reduction in disease specific mortality was impressive, with the overall death rate from neoplasms being 60% lower for SDA men and 76% lower for SDA women.[3, 5] The incidence of breast and colorectal cancer were dramatically lower than in the control population with SDA women experiencing 85% less breast cancer [6-8]and SDA men and women experiencing 62% less colorectal cancer.[3, 9, 10]The incidence of coronary heart disease (CHD) was 66% lower for SDA men and 98% lower for SDA women.[11-13] On average Adventist men live 7.3 years longer and Adventist women live 4.4 years longer than other Californians.

The second Adventist Health Study (AHS-2) took place in the time period between 1974 and 1988 and involved approximately 34,000 Californian Adventists over the age of 25. AHS-2 was designed to try to determine which components of the SDA lifestyle provided protection against specific types of disease. The AHS-2 found that the consumption of red and white meat was associated with an increase of colon cancer and that, independent of meat consumption, eating legumes was protective against the disease.[5, 10, 14] The consumption of nuts was found to be inversely related to the incidence of myocardial infarction, and regular consumption of nuts several times a week reduced the incidence of coronary heard disease CHD by ~50%.[15-17] A strong inverse relationship was found between the risk of CHD and the consumption whole grain wheat bread, as opposed to white bread (~45% reduction in CAD).[16] In men, the frequent consumption of tomatoes and of soy milk was associated with a ~60% reduction in the incidence of prostate cancer.[16, 18, 19]

Figure 2: Survival of California Adventist women (1980-1988) and other California women (1985) beyond the age of 30 years. The difference between the 2 groups was significant (P,.001). These were non-Hispanic white subjects. Hazards for 1989 are used for non-Adventist Californians older than 94 years (see the “Subjects and Methods” section of the text). AHS indicates Adventist Health Study; CI, confidence interval.

Unlike the Cretan diet, the dietary practices of the SDAs are less homogenous and typically incorporate foods commonly consumed by Americans (although with more moderation), including many associated with degenerative disease, such as refined sugar and snack foods. Similarly, the SDA diet typically strives to replace traditional American foods with healthier alternatives, while maintaining the flavor, texture and appearance of the original dishes.[20] One way this is done is by using a range of proprietary textured vegetable protein products (TVP) derived from wheat or soy (with corn or soy oil providing the calories from fat) as meat substitutes. There is also a heavy emphasis on the consumption of vegetables, nuts, whole grains and fruits.[21, 22]

Figure 3: Examples of textured vegetable protein products made to resemble commonly eaten meat dishes in the US.

These products have historically been manufactured by companies owned by or closely associated with the SDA church[23] and this was an added factor in their widespread use. Lentils are also often substituted for meat in traditional American recipes, such as meatloaf and soup. The use of TVP meat substitutes increase compliance by making products that allow for the preparation of foods that fill the cultural niche of beef, chicken and turkey. There are even faux-meat hot dogs available (Figure 3). Nuts are also commonly used as an ingredient in TVP dishes to provide added flavor and a more meat-like mouth feel.[20] Examples of commonly used SDA “meatless meat products” (Figure 3) along with their ingredients and nutritional content are available at http://fatsecret.com/calories-nutrition/worthington-loma-linda#Meatless_Foods.

The primary sources of lipids in the SDA diet have historically been from corn and soy oils, and to a lesser extent oils from nuts (corn oil has partly been replaced by canola oil in the contemporary SDA diet). In examining the commonalities between the SDA and the Cretan diet, the following components seem the most likely candidates to explain the reduction in morbidity and mortality observed in both populations:

  • No or very low consumption of red meat
  • No or low consumption of meat (excluding fish) in general
  • Large consumption of fresh fruits and vegetables
  • Use of free range hens’ eggs
  • No or low consumption of butter
  • No or low consumption of unfermented milk products
  • Emphasis on legumes in the diet
  • Emphasis on the regular consumption of nuts
  • Fat intake primarily in the form of polyunsaturated or monounsaturated fats of vegetable origin
  • Regular exercise
  • Maintenance of near ideal body weight over the lifespan
  • Abstention from smoking

Which Diet for a New Lifestyle?

Figure 4: The Greek Food Column and the three critically important lifestyle elements that accompany it; balance, proportionality and regular exercise.

The Lyon Heart Study clearly showed that the diet of Crete can be adhered to over a period of 5 years. Figure 4 is the Greek Column Food Guide based on the diet of Crete. The visualization of this food guide in the form of a Greek column includes the concepts of genetic variation and nutrition and balanced energy intake and energy expenditure; it is based on foods, not food groups. Although it excludes certain foods made with hydrogenated oils, it does not restrict the intake of naturally occurring foods. It also takes into consideration moderation, variety and proportionality. Dietary guidelines shown in Table 1 provide further information on how to implement the diet of Crete.

Table 1.
The seven dietary guidelines of The Cretan Diet
1. Eat foods rich in (n-3) fatty acids such as fatty fish (salmon, tuna,
trout, herring, mackerel), walnuts, canola oil, flaxseeds and green
leafy vegetables. Or, if you prefer, take (n-3) supplements.
2. Use monounsaturated oils such as olive oil and canola oil as your
primary fat.
3. Eat seven or more servings of fruits and vegetables every day.
4. Eat more vegetable protein, including peas, beans and nuts.
5. Avoid saturated fat by choosing lean meat over fatty meat (if you
eat meat) and low fat over full fat milk products.
6. Avoid oils that are high in (n-6) fatty acids, including corn,
safflower, sunflower, soybean, and cottonseed oils.
7. Reduce your intake of trans fatty acids by cutting back on
margarine; vegetable shortening; commercial pastries; deep-fat
fried food; and most prepared snacks, mixes and convenience
food.

Studies on the diets of hunter-gatherers suggest that (n-3) fatty acids were present in practically all foods that humans ate, and present in equal amounts with (n-6) fatty acids (i.e., 1:1 ratio). The depletion of the (n-3) fatty acids in Western diets is the result of the industrialization of farming, and to a lesser extent, the recent emergence of aquaculture. The high ratio of (n-6) to (n-3) fatty acids (16.74:1 instead of 1:1) is a consequence of the inexpensive mass production of vegetable oils and their substitution in much of the diet for saturated fats as a consequence of economic considerations, government policy (corn and soy subsidies) and erroneous health advice by the “experts.” The latter, led by Ancel Keyes,  recommended the indiscriminate substitution of saturated fat and butter with oils high in (n-6) fatty acids to lower serum cholesterol. This effort was successful in reducing the incidence of CVD, however it has not reduced the incidence of other pro-inflammatory diseases, and the mean lifespan has not increased fully commensurate with the decrease in CVD mortality.

The results of the Seven Countries Studies and the Lyon Heart Study based on a modified Cretan diet that is balanced in (n-6) and (n-3) fatty acids, rich in antioxidant micronutrients, and in chemoprotective trace minerals  from fruits, vegetables, wild growing herbs and greens is associated with decreased rates of heart disease and cancer; more so than any other diet, drug intervention, or technique. Indeed, all attempts to date to administer nutrients believed to be protective against disease as supplements have been unsuccessful. Attempts to reduce the incidence of CVD with vitamin C, vitamin E and with folic acid and vitamin B-6 (the latter to achieve reduction in elevated serum homocyeteine levels) have failed, suggesting that the biochemical protection these molecules provide in vitro, and in laboratory animal settings, requires the presence of other molecular species in order to act in vivo.

What appears to be unique about the Cretan (and to a lesser extent the SDA diet) is the content of bioprotective nutrients with a broad range of action, specifically the following: 1) a more balanced intake of essemtial fatty acids (EFAs) from vegetable, animal and marine sources; a ratio of (n-6) to (n-3) fatty acids of ;2:1 instead of the 15:1 in most Western diets (it is 16.74:1 in the US); and 2) a diet rich in antioxidants, i.e., high in vitamin C, vitamin E, b-carotene, glutathione, resveratrol, selenium, phytoestrogens, folate, and other phytochemicals from green leafy vegetables; phenolic compounds from wine and olive oil; high intakes of tomatoes, onions, garlic and herbs, especially oregano, mint, rosemary, parsley and dill, which contain  lycopene, allyl thiosulfinates, salicylates, carotenoids, indoles, onoterpenes, polyphenols, flavonoids and other phytochemicals used in cooking vegetables, meat and fish.

Some Serious Caveats Regarding the Applicability of Historical Data

In asking people about how long they expect to live, I’m often surprised by the high degree of confidence they exhibit based on the longevity of relatives. If you challenge the assumption that because their aunts, uncles or parents lived into their 80s or 90s that they will too, you will likely be met with the vehement assertion that this fact pretty much guarantees a similar outcome for the respondents. This assertion would be more credible if their long lived 1st or 3rd degree kin were reared under identical, or at least under similar conditions. And therein lies the rub, because this is usually not the case.

Figure 5: Average weekly hours spent on home production from 1900 to 2000 for two aggregates of the population; those in their productive prime, and those in their declining years.

It must be remembered in making historical comparisons with contemporary Westerners in terms of both life expectancy, and dietary or other interventional lifespan studies, that 20th century Cretans and Adventists were, of necessity, far less sedentary than is the average 21st century Westerner today. In this cohort of people housework (household production) involved a considerable amount of exercise, and often no small amount of hard physical labor. Until the middle of the 20th century in the US, laundry was done by hand, in whole or in part, and clothing was hung up to dry, taken down and ironed. Even operating automobiles involved clutching, shifting gears and manual operation of windows – small things by themselves, but cumulatively important.

Figure 6: Between 1950 and 2000 there was a ~ 20% reduction in the types of work classified as “high activity.” What is neither shown nor known is the degree to which both high and low activity jobs have become less strenuous. [24]

Meal preparation in 1965 required ~ 16.5 hours per week and the total numbers of hours spent in home production was on the order of 51.8 hours at that time. [25] As can be seen in Figure 5, time spent on home production decreased significantly beginning around 1960. Beyond the decrease in total hours spent on housework, there was a much larger decrease in the amount of physical effort required. Washing machines and clothes dryers, prepared meal components and entire prepared meals, as well as countless other “labor saving” devices, goods and services have markedly decreased fitness. The same has been true of strenuous physical activity in the work place where the overall number of high activity jobs have decreased by ~ 20% from 1970-2000.[26, 27]  There has also been a large shift in the workplace demographic since the mid-2oth century. Life expectancy increased from 47.3[28] years in 1900 to 77.8 years today, a consequence of which (in part) was the exodus of teens from the workforce. In 1920, ~20% of the US labor force was comprised of males aged 15 to 18 years of age.[28] Today, very few teenagers work full time jobs, and the number of teens employed in summer jobs has decreased from ~60% in 1994, to ~40% in 2008.[29] Of those teens who do find summer employment very few are in physically demanding (and consequently usually hazardous) areas of work, such as construction or agriculture. This change, coupled with increased TV viewing and other sedentary activities, translates into reduced fitness in the age 15-30 demographic.

Figure 7: The graph above shows the distribution of the Body Mass Index between the 1971–1975 and 1988–1994 surveys. Over this time, median BMI increased by 0.9; the 75th percentile increased by 1.5; and the 95th percentile increased by 2.7.[238]

In their article, “Why Have Americans Become More Obese?” Cutler, et al., take the contrary position and argue that it is not reduced energy expenditure (or fitness) in the the population, but rather, the reduced investment required in terms of time per calorie consumed, that has been the primary cause of the change in US, and increasingly Western European eating habits (and thus is responsible for the current epidemic of obesity and type II diabetes).[30] Superior food packaging and preservation have cut not just meal preparation time dramatically, but also cleanup time. The mess generated in the preparation of multiple elements of a meal is now confined to the factory and the cleanup is included in the price of the food. It is also no longer necessary to spend as much time cooking, or even heating food, because it can be rapidly prepared and be made ready to eat in a matter of minutes from refrigerator or cupboard by the use of the microwave oven. These technological changes have thus reduced the threshold for eating formerly time consuming and messy to prepare dishes to the point of almost no effort or expenditure of time at all. It is now almost as easy to eat a piece of cake or pie, a brownie, or complex entree as it once was to eat an apple. All the mess and time involved in baking a cake or a pie from scratch is gone.

Regardless of the cause, we are most certainly not our parents or our grandparents, and as the current epidemic of obesity and type II diabetes attests, we are not likely to age or die as they did, either. Any doubts about the difference between “us” and “them” (or even “us then” and “us now”) should be laid to rest by a careful perusal of Figure 7.

The generations who participated in the AHS and Seven Countries Study were also fed differently. In Europe, they were subjected to nearly a decade of reduced calorie consumption, and even in the US, the relatively high cost of calories (in time, if nothing else) combined with less leisure time and fewer options for sedentary work, no doubt acted to limit calorie consumption, compared to today. This reduced calorie consumption may have been protective, and might have served to add years to life even in the presence or the absence of a more optimal diet. These generations of people were also fed on agricultural products derived mostly from small farms where crops and livestock had the opportunity to acquire a broad range of micro-nutrients and phytochemicals that are now less abundant in the food supply.

How Square is Curve Already?

Figure 8: The death rate from cardiovascular disease in the US has plummeted since the turn of century in part due to the replacement of saturated fats with of polyunsaturated fats in the diet.[31]

It should also be pointed out that data from longitudinal studies like the AHS-1&2 and the Seven Countries Study reach us as light does from a distant star. When we point and look at the star in the crook of the handle of the Big Dipper we say, “Look, there’s Alcor!” But of course that isn’t the Alcors we are looking at, but rather the light that shows what they looked like 83 years ago. Similarly, all of the data in AHS-1&2 and Seven Countries Study is a generation or two (or three!) old by the time we have it. The participants in those studies are mostly dead now, as indeed they would have to be in order for us to be able to plot lifespan curves for them. Thus, it is easy to make the mistake of saying, “If I adopt this diet I can expect 7 additional years of life, or 10 additional years of life, because that’s what the study participants experienced.

At least one problem with that assumption is that some of the benefits from both studies have very likely already been realized in the form of the switch from saturated to poly- and monounsaturated fats in the diet, which began in the early 1960s and continues through the present. The most significant benefit from both the Seven Countries Cretan diet and the Adventist Vegetarian diet has been the reduction in mortality (and morbidity) from CVD that has been ongoing since ~1968 in the US. The death rate from CVD has been halved since 1960 when both of these studies were undertaken (Figure 8). To those who vilify Ancel Keys for not getting it just right, I can only say, “Look at (Figure 8) and try to tell me that you could have done better.” So, we’ve undoubtedly used up some of benefit from these dietary interventions in terms of mean lifespan extension.

Figure 9: These curves show the best case extension of mean lifespan that can be anticipated with the Adventist Vegetarian diet or the Cretan Diet.

Finally, it is critically important to understand that both the Cretan and the Adventist Vegetarian diets are really not “diets” at all, but rather lifestyles. Both lifestyles have in common a strong emphasis on low impact exercise and a non-sedentary way of life. Both lifestyles were a product of a time without televisions or computers, and both lifestyles required then, and will require now, considerably greater time for food preparation and cleanup. The upside of that is that we should also eat less, if Cutler et al., are correct. That is important to consider as well, because, leaving aside whether fats, carbohydrates or protein should comprise X- percentage of a given diet’s calories, one thing both these diets have in common is modest to moderate calorie restriction.  Five, or possibly even 10 extra years of healthy, productive life should hopefully make the practical costs worthwhile.

The Caveman Diet, or Just How Credulous Are You?

“There are races of people who are all slim, who are stronger and faster than us. They all have straight teeth and perfect eyesight. Arthritis, diabetes, hypertension, heart disease, stroke, depression, schizophrenia and cancer are absolute rarities for them. These people are the last 84 tribes of hunter-gatherers in the world. They share a secret that is over 2 million years old. Their secret is their diet- a diet that has changed little from that of the first humans 2 million years ago, and their predecessors up to 7 million years ago. Theirs is the diet that man evolved on, the diet that is coded for in our genes. It has some major differences to the diet of “civilization”. You are in for a few big surprises.

The basic principles of the Paleolithic Diet are so simple that most high school students can understand them. Within 15 minutes from now you will grasp the major elements. At the technical level, Paleolithic Diet Theory has a depth and breadth that is unmatched by all other dietary theories.” – Dr. Ben Balzer, M.D.

The ideas underlying the Cretan Diet and the SDA Vegetarian diet are complex and do not admit of easy reduction to a catchphrase. The actual foods permitted and consumed in both diets differ markedly – one proscribing all meat, the other urging fish consumption, one obtaining most of the dietary fat calories from PUFAs, and the other from monounsaturated olive oil… It is these differences in the face of the common outcome of greatly improved health and moderate extension of the mean lifespan that are, in fact, key, because they tell us about the likely underlying common mechanisms and thus possibly of their action. They also offer us the opportunity for more choice, and therefore for more flexibility and the likelihood of greater compliance.

The Paleo Diet: A diet so unscientific, only a caveman would do it.

That is not, however, how people make a quick buck. Neither diet is particularly ‘sexy.’ And both diets require an understanding of the underlying biology that makes them work in order to be credible. It’s not possible, or at least not as easy to offer up a one sentence explanation for the feeble minded, such as, “This is a healthy diet that will extend lifespan because it is the natural human diet that our ancestors were evolved to eat.”[32-34] That sounds great because it is simple, easy to understand and “seems right” to a lot of uninformed, ignorant and fearful people. It also speaks to that deep and abiding suspicion that our health (and our other woes) is an artifact of our having lost our way – either from the primordial Garden of Eden, or from our biologically appropriate evolutionary ground state (i.e., before we embarked on agriculture). In fact, the emphasis on a 1:1 or 2:1 ratio of (n-6) to (n-3) fatty acids was derived from observations of contemporary hunter gatherer populations who have a low incidence of inflammatory and age-associated degenerative disease compared to that seen in post-agricultural populations. That was a useful insight that was subsequently validated in many human studies, the best of which extended over a period of decades. That’s the heart and soul of Level 1, Evidence Based Medicine.

In 1988, S. Boyd Eaton, Marjorie Shostak and Melvin Konner published a book entitled The Paleolithic Prescription: A Program of Diet & Exercise and a Design for Living[32] advocating a diet based on what the authors hypothesized the primordial pre-agricultural human diet was like. Subsequently, well over a dozen books have been published advocating variations on this diet based on arm chair hypothesizing from findings in the scientific and ethnographic literature.  The diet (depending upon the version you come across) is low (10-15% energy) or moderate in fat , low in carbohydrate (20–40% energy), and  high in protein diet (19–35% energy) which provides 55–65% of total calories from meat, 35–45% of calories from non-grain and low glycemic index vegetable sources with a primarily saturated fat intake (10%–58% energy) similar to or higher than that found in Western diets.[35-37]

The first problem with this approach is that the diet is not validated; the AHS and the Seven Counties studies had the considerable advantage of being able to study actual, living human beings under real world conditions, and then apply those insights to other populations, including populations already suffering from CVD. Indeed, that is where so many of the insights, as well as so many of the unresolved questions regarding these diets/lifestyles come from (i.e., the data are complex and robust). Late Paleolithic people are not only long dead and gone, they are really long dead and gone, and contemporary hunter gatherers – the few that remain – cannot be considered equivalent. Ironically, most of the data cited on the relationship between CVD and diet by the originators of the Paleolithic diet are from the Seven Countries Study![32, 37]

Even more to the point, there is present in the hypothesis of Eaton, Konner et al.,[32, 33] the notion that 10,000 years of agriculture is evolutionarily insignificant. In essence, they posit that human evolution with respect to diet stopped 10,000 years ago.[32, 35] At first glance this might seem to be credible, because human evolution has occurred over a period of millions years and it would seem that any changes that would occur in population genetics over a mere 10,000 years must be trivial. However, this is not the case for several reasons. First, the rate of evolution is a function of a complex interplay of multiple factors, including environmental change and selection pressure. It is only necessary to look at the various breeds of dogs, or pigeons created by artificial selection to understand that evolutionary change can be swift.

The introduction of agriculture was a watershed event and it would be astonishing if it was not accompanied by significant evolutionary adaptations to the dietary changes that resulted.  To understand that this is so it is only necessary to examine the strong natural selection for the gene that controls lactase production.[38] Human populations with a long history of cattle herding and milk consumption can metabolize lactose present in cow’s milk throughout adulthood, whereas populations that did not domesticate cattle cannot. Natural selection for the heterozygous carriers of the sickle-cell gene to maintain sickle-cell trait in populations exposed to malaria is another post-advent of agriculture evolutionary adaptation. This adaptation was selected for as a direct result of an agriculture-induced alteration to the environment; the clearance of the tropical forests in central Africa, which in turn led to the explosion in the population of the Anopheles mosquitoes that are the vectors for the Plasmodium parasite that causes malaria.

Recently developed techniques for measuring genetic variability now allow for the determination of selection operating in the human genome.[39] Directional selection has been identified in the glucose-6-phosphate dehydrogenase (G6PD) gene, which confers resistance to malaria.[40] What is more, G6PD resistance has evolved not once, but twice in humans, in both Africa and in the Americas.[41] Similarly, the genes expressing chemokine receptor 5 (CCR5) among Europeans, which confers resistance to the human immunodeficiency virus (HIV) are likely to have been selected for within this population over a period of several hundred years in response to Yersinia pestis (bubonic plague) and tuberculosis, both of which use the CCR5 receptor as an entry portal into the host.[42]  Numerous other studies have also provided evidence for the recent operation of natural selection on the human genome as a result of very recently developed techniques that allow for comparisons over long sections of DNA.[43-46]

In addition to the conservation of lactase production into adulthood, there is substantial evidence of evolutionary adaptation to the high carbohydrate diet that was a product of agriculture. The incidence of obesity that occurs upon exposure to high calorie “affluence diets” is known to vary greatly by ethnicity. The Pima people (or Akimel O’odham) are a racial group of Amerindians living in central and southern Arizona. One-half of adult Pima Indians have diabetes and 95% of those with diabetes are overweight or obese.

Obesity is thought to be 50-90% heritable. Genome scans in obesity studies are highly reproducible and, despite ethnic and environmental differences, the loci at chromosomes 2 and 10 are generally confirmed as the source of the phenotype. Obesity is “oligogenic,” with expression modulated by “polygenic modifier genes” interacting with the environment in food choices, physical activity, and smoking.[38] Prior to their introduction to the “American” diet after WWII the Pima were not obese and diabetes was extremely rare.[39-41] The diet of the Pima was a very low fat, high carbohydrate diet consistent with the subsistence agriculture of the desert southwest.[42, 43]  Some variations in the ectonucleotide pyrophosphatase phosphodiesterase gene-1 (ENPP1) are associated with a 50% increase in the risk of morbid obesity in adults and a 69% increased risk of childhood obesity. An ENPP1 mutation, for example, which is known to protect against obesity and type II diabetes, is present in about 90 percent of non-Africans, but nearly absent in Africans and, not coincidentally, in the Pima. Human evolution in response to environmental change and in response to dietary change is both ongoing and dynamic.[47][44]

Of course, the Paleolithic diet may be the best diet yet conceived. I could give many reasons why I believe this is not so, but absent hard data gleaned from human trials, I can’t prove much. And that is my final and most important point. I did a Pubmed search using the keywords “Paleolithic diet” and I got 67 hits. Of those 67 hits only 9 were papers that involved actual human or animal application of the diet, or even discussion of same. I’ve copied all of the cites for these studies below:

1: Konner M, Eaton SB. Paleolithic nutrition: twenty-five years later. Nutr Clin Pract. 2010 Dec;25(6):594-602. PubMed PMID: 21139123.

2: Jönsson T, Granfeldt Y, Erlanson-Albertsson C, Ahrén B, Lindeberg S. Apaleolithic diet is more satiating per calorie than a Mediterranean-like diet in  individuals with ischemic heart disease. Nutr Metab (Lond). 2010 Nov 30;7:85. PubMed PMID: 21118562; PubMed Central PMCID: PMC3009971.

3: Klonoff DC. The beneficial effects of a Paleolithic diet on type 2 diabetes and other risk factors for cardiovascular disease. J Diabetes Sci Technol. 2009 Nov 1;3(6):1229-32. PubMed PMID: 20144375; PubMed Central PMCID: PMC2787021.

4: Eaton SB, Konner MJ, Cordain L. Diet-dependent acid load, Paleolithic[corrected] nutrition, and evolutionary health promotion. Am J Clin Nutr. 2010 Feb;91(2):295-7. Epub 2009 Dec 30. Erratum in: Am J Clin Nutr. 2010 Apr;91(4):1072. PubMed PMID: 20042522.

5: Jönsson T, Granfeldt Y, Ahrén B, Branell UC, Pålsson G, Hansson A, Söderström  M, Lindeberg S. Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study. Cardiovasc Diabetol. 2009 Jul 16;8:35. PubMed PMID: 19604407; PubMed Central PMCID: PMC2724493.

6: Frassetto LA, Schloetter M, Mietus-Synder M, Morris RC Jr, Sebastian A. Metabolic and physiologic improvements from consuming a paleolithic, hunter-gatherer type diet. Eur J Clin Nutr. 2009 Aug;63(8):947-55. Epub 2009 Feb  11. PubMed PMID: 19209185.

7: Osterdahl M, Kocturk T, Koochek A, Wändell PE. Effects of a short-term intervention with a paleolithic diet in healthy volunteers. Eur J Clin Nutr. 2008 May;62(5):682-5. Epub 2007 May 16. PubMed PMID: 17522610.

8: Jönsson T, Ahrén B, Pacini G, Sundler F, Wierup N, Steen S, Sjöberg T, Ugander M, Frostegård J, Göransson L, Lindeberg S. A Paleolithic diet confers higher insulin sensitivity, lower C-reactive protein and lower blood pressure than a cereal-based diet in domestic pigs. Nutr Metab (Lond). 2006 Nov 2;3:39. PubMed PMID: 17081292; PubMed Central PMCID: PMC1635051.

9: Eaton SB, Eaton SB 3rd. Paleolithic vs. modern diets—selected pathophysiological implications. Eur J Nutr. 2000 Apr;39(2):67-70. PubMed PMID: 10918987.

If I enter the keywords “Mediterranean diet” I get 2,269 hits, of which 225 are reports of clinical trials. I will not copy those here!

That’s it. Nine papers of poor quality and not a single clinical trial demonstrating reduced morbidity or mortality – even in CHD or type II diabetes.  Sixty-seven papers of hypothesizing 25 years after this diet was put forth. That is dismal science and it is inexcusable to take a position advocating such an intervention in the complete absence of any evidence that it will actually extend the human (or the laboratory animal) lifespan when there is a large body of high quality data that supports far less extreme, and far more practical dietary and lifestyle interventions that will accomplish those ends.

I have no problem with people coming up with a hypothesis, however kooky or sane, and then proceeding to try it out – even on people – as long as those people have informed consent and the data they are given is accurate. In looking over the various books and the countless media articles on the Paleolithic diet, I was struck by how much the Paleolithic Diet’s hype reminded me of the Pritikin diet hype, and even more so of the Pearson & Shaw Life Extension Revolution circus from 30 years ago. “Live to be 100!” “Feel great! Experience all day energy every day!” “Lose Weight!” Well, at least one of those is very likely true, and that is that most people who undertake any version of the Paleo diets I’ve reviewed will likely lose weight. But as to the other claims? Right now they are preposterous. The sad thing is that for first the time in history we have one diet/lifestyle choice that satisfies EBM-1 criteria, and another that satisfies EBM-2 criteria. Both are “proven” to reduce morbidity from a range of degenerative diseases, and both have been proven to significantly extend mean lifespan…

Max More, CEO Alcor Life Extension Foundation

As I so often say, “You pays your money and you takes your chances.” Still,  it is embarrassing to see cryonicists buy into yet another quick fix cure all, with no appropriate science to back it up. In his article “The Cryo-Paelo Solution”[48] Alcor President Max More advocates the Paleolithic Diet as a life extending add-on to cryonics. This recommendation is supplemented by a web interview.[49] His citations consist these of these popular books on the subject: Loren Cordain, The Paleo Diet; Nora T. Gedgaudas, Primal Body, Primal Mind; Mark Sisson, The Primal Blueprint; Gary Taubes, Why We Get Fat;Gary Taubes, Good Calories, Bad Calories; Arthur de Vany, The New Evolution Diet. The expert More cites as the one to consult for an introduction to Paleo-dieting is Loren Cordain, author of  The Paleo Diet. The quote that open this section on the Paleolithic diet is by Dr. Ben Balzer, M.D., and is from the “Introduction” to Cordrain’s book. Need I say more?

End of Part 3

References

1.            White E: Ministry of Healing: http://books.google.com/books/about/The_Ministry_of_Healing.html?id=2bu2ry223JAC: Kessinger Publishing, LLC; 1905.

2.            Rucker C: The Seventh-Day Diet: A Practical Plan to Apply the Adventist Lifestyle to Live Longer, Healthier, and Slimmer in the 21st Century: Pacific Press Publishing Association 2002.

3.            Mills PK, Beeson WL, Phillips RL, Fraser GE: Cancer incidence among California Seventh-Day Adventists, 1976-1982. Am J Clin Nutr 1994, 59(5 Suppl):1136S-1142S.

4.            Kahn HA, Phillips RL, Snowdon DA, Choi W: Association between reported diet and all-cause mortality. Twenty-one-year follow-up on 27,530 adult Seventh-Day Adventists. Am J Epidemiol 1984, 119(5):775-787.

5.            Grundmann E: Cancer morbidity and mortality in USA Mormons and Seventh-day Adventists. Arch Anat Cytol Pathol 1992, 40(2-3):73-78.

6.            Zollinger TW, Phillips RL, Kuzma JW: Breast cancer survival rates among Seventh-day Adventists and non-Seventh-day Adventists. Am J Epidemiol 1984, 119(4):503-509.

7.            Fraser GE: Diet as primordial prevention in Seventh-Day Adventists. Prev Med 1999, 29(6 Pt 2):S18-23.

8.            Mills PK, Annegers JF, Phillips RL: Animal product consumption and subsequent fatal breast cancer risk among Seventh-day Adventists. Am J Epidemiol 1988, 127(3):440-453.

9.            Mills PK, Beeson WL, Phillips RL, Fraser GE: Bladder cancer in a low risk population: results from the Adventist Health Study. Am J Epidemiol 1991, 133(3):230-239.

10.          Phillips RL, Snowdon DA: Dietary relationships with fatal colorectal cancer among Seventh-Day Adventists. J Natl Cancer Inst 1985, 74(2):307-317.

11.          Fraser GE, Dysinger W, Best C, Chan R: Ischemic heart disease risk factors in middle-aged Seventh-day Adventist men and their neighbors. Am J Epidemiol 1987, 126(4):638-646.

12.          Fraser GE, Lindsted KD, Beeson WL: Effect of risk factor values on lifetime risk of and age at first coronary event. The Adventist Health Study. Am J Epidemiol 1995, 142(7):746-758.

13.          Fraser GE, Shavlik DJ: Risk factors for all-cause and coronary heart disease mortality in the oldest-old. The Adventist Health Study. Arch Intern Med 1997, 157(19):2249-2258.

14.          Giem P, Beeson WL, Fraser GE: The incidence of dementia and intake of animal products: preliminary findings from the Adventist Health Study. Neuroepidemiology 1993, 12(1):28-36.

15.          Fraser GE, Sabate J, Beeson WL, Strahan TM: A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study. Arch Intern Med 1992, 152(7):1416-1424.

16.          Fraser GE: Associations between diet and cancer, ischemic heart disease, and all-cause mortality in non-Hispanic white California Seventh-day Adventists. Am J Clin Nutr 1999, 70(3 Suppl):532S-538S.

17.          Sabate J: Nut consumption, vegetarian diets, ischemic heart disease risk, and all-cause mortality: evidence from epidemiologic studies. Am J Clin Nutr 1999, 70(3 Suppl):500S-503S.

18.          Willett W: Lessons from dietary studies in Adventists and questions for the future. Am J Clin Nutr 2003, 78(3 Suppl):539S-543S.

19.          Phillips RL, Snowdon DA: Association of meat and coffee use with cancers of the large bowel, breast, and prostate among Seventh-Day Adventists: preliminary results. Cancer Res 1983, 43(5 Suppl):2403s-2408s.

20.          Beck J, Beck, JJ, Jarnes, K.: Adventist Sabbath Dinner Cookbook: Pacific Press Publishing Association; 2001.

21.          Council GCoS-dAN: The Seventh-day Adventist Position Statement on Vegetarian Diets: http://www.sdada.org/position.htm. In.; 2010.

22.          Health LLUSoP: The Vegetarian Food Pyramid: http://www.vegetariannutrition.org/food-pyramid.pdf. In. Loma Linda: Loma Linda University; 2008.

23.          Center S: History of Loma Linda Foods: http://www.soyinfocenter.com/HSS/loma_linda_foods.php. In. Lafayette: Soyinfo Center; 2004.

24.          King G, Fitzhugh, EC, Bassett, DR Jr, McLaughlin, JE, Strath SJ, et al.: Relationship of leisure-time physical activity and occupational activity to the prevalence of obesity. Int J Obes Relat Metab Disord 2001, 25:606-612.

25.          Ramey V: Time Spent in Home Production in the Twentieth-Century United States: New Estimates from Old Data :http://weber.ucsd.edu/~vramey/research/Home_Production_published.pdf. The Journal of Economic History 2009, 59(1).

26.          Borodulin K, Laatikainen, T, Juolevi, A, Jousilahti, P. : Thirty-year trends of physical activity in relation to age, calendar time and birth cohort in Finnish adults. Eur J Public Health 2008, 18(3):339-344.

27.          Brownson R, Boehmer, TK, Luke, DA.: Declining rates of physical activity in the United States: what are the contributors. Annu Rev Public Health 2005, 26(421-43).

28.          Census USBot: U.S. Bureau of the Census, Historical Statistics of the United States, Colonial Times to 1970. 1971.

29.          Camarota S, Jensenius, K. : A Drought of Summer Jobs: Immigration and the Long-Term Decline in Employment Among U.S.-Born Teenagers: http://www.cis.org/articles/2010/teen-study.pdf. In: Backgrounder. Center for Immigration Studies; 2010.

30.          Cutler D, Glaeser, EL, Shapiro, JM.: Why have americans become more obese? Journal of Economic Perspectives 2003 17(3):93-118.

31.          National Heart LaBI: Morbidity & mortality: 1998 chartbook on cardiovascular, lung, and blood diseases. In. Edited by Health UDoHaHSNIo. Rockville, Maryland: US Government Printing Office; 1998.

32.          Eaton S, Shostak, M, Konner, M.: The Paleolithic Prescription: A Program of Diet & Exercise and a Design for Living. New York:: Harper & Row; 1988.

33.          Konner M, Eaton SB: Paleolithic nutrition: twenty-five years later. Nutr Clin Pract, 25(6):594-602.

34.          Lindeberg S: [Paleolithic diet and evolution medicine: the key to diseases of the western world]. Lakartidningen 2005, 102(26-27):1976-1978.

35.          O’Keefe J, Cordain L.: Cardiovascular Disease Resulting From a Diet and Lifestyle at Odds With Our Paleolithic Genome: How to Become a 21st-Century Hunter-Gatherer. Mayo Clin Proc 2004;, 79:101-108.

36.          Cordain L, Eaton SB, Miller JB, Mann N, Hill K: The paradoxical nature of hunter-gatherer diets: meat-based, yet non-atherogenic. Eur J Clin Nutr 2002, 56 Suppl 1:S42-52.

37.          Marlowe F: Hunter-gatherers and human evolution. Evolutionary Anthropology 2005, 14:54 -67.

38.          Froguel P, Boutin P: Genetics of pathways regulating body weight in the development of obesity in humans. Exp Biol Med (Maywood) 2001, 226(11):991-996.

39.          Bennett PH, Burch TA, Miller M: Diabetes mellitus in American (Pima) Indians. Lancet 1971, 2(7716):125-128.

40.          Bennett PH, Rushforth NB, Miller M, LeCompte PM: Epidemiologic studies of diabetes in the Pima Indians. Recent Prog Horm Res 1976, 32:333-376.

41.          Zimmet P, Arblaster M, Thoma K: The effect of westernization on native populations. Studies on a Micronesian community with a high diabetes prevalence. Aust N Z J Med 1978, 8(2):141-146.

42.          Ravussin E, Valencia ME, Esparza J, Bennett PH, Schulz LO: Effects of a traditional lifestyle on obesity in Pima Indians. Diabetes Care 1994, 17(9):1067-1074.

43.          Boyce VL, Swinburn BA: The traditional Pima Indian diet. Composition and adaptation for use in a dietary intervention study. Diabetes Care 1993, 16(1):369-371.

44.          Malhotra A, Kobes S, Knowler WC, Baier LJ, Bogardus C, Hanson RL: A Genome-Wide Association Study of BMI in American Indians. Obesity (Silver Spring).

45.          More M: The cryo-paelo solution: http://www.alcor.org/magazine/2011/03/07/the-cryo-paleo-solution/. Cryonics (on line edition) 2011.

46.          Snyder S: Alcor CEO Max More and the paleo diet: http://samsnyder.com/2011/05/22/alcor-ceo-max-more-and-the-paleo-diet/. In: A Blog by Sam Snyder. Sam Snyder; 2011.

 

Posted in Gerontology | 50 Comments

Interventive Gerontology 1.0.02: First, Try to Make it to the Mean: Diet as a life extending tool, Part 2

Figure 1: Ancel Keys (January 26, 1904 – November 20, 2004) was the American physiologist and epidemiology of cardiovascular disease (CVD). He was responsible for two famous diets: K-rations formulated as balanced meals with a long shelf life for combat soldiers in World War II and the Mediterranean (Cretan) diet. Keys is shown (at right, above) two months before his 101st birthday.

The Seven Countries and Adventist Health Studies

Nathan Pritikin drew his initial conclusions about the effect of dietary change from classified data he was privy to during World War II (WWII) on the patterns of age-associated disease in Europe as a consequence wartime calorie restriction and severe reduction of fat intake due to the severely reduced availability of meat and dairy products.  He also observed that the incidence of age-associated degenerative diseases was  very low in human populations where the diet was very low in fat (~10% of the total caloric intake), contained no refined sugars and consisted mostly of fresh vegetables and fruits  with very little meat being consumed. Similarly, the physiologist Ancel Keys (Figure 1), who was working with the Army Quartermaster Corps in developing K-Rations,[1] became involved in the Army’s program to create scientifically informed re-feeding programs for POWs and civilians suffering from starvation, saw the same kind of data. Unlike Pritikin, Keys had the opportunity to do human experimentation afforded by wartime conditions.[2, 3] Keys working hypothesis was different than Pritkin’s, namely that it was primarily saturated fats in the diet that were responsible for the high incidence of cardiovascular disease (CVD) in the affluent and well-fed West.

This epidemiological approach to identifying patterns of food consumption associated with increased or reduced risk of degenerative disease was also being pursued around this time in the US, by physicians at the Loma Linda Medical Center in Loma Linda, CA. Loma Linda was an almost exclusively Seventh Day Adventist community at that time, and these physicians believed that their patients, who practiced a vegetarian diet in conjunction with abstention from tobacco and alcohol, were considerably healthier than the non-Adventist population in California. They began a study of diet, lifestyle and the incidence of disease and all-cause mortality in 1958; the Adventist Health Study-1 (AHS-1) [4-26]

Keys returned to Europe after the war and began a study of six European countries, which later became the Seven Countries Study. [27-72] The dietary recommendations which emerged from the Seven Countries Study are commonly referred to as the “Mediterranean diet.” However, the use of the words “Mediterranean diet” to describe these recommendations is a misnomer. The countries of the Mediterranean basin have large differences in diet, lifestyle and in their corresponding rates of morbidly and mortality. The country with the lowest death rate  (14.0 – 18.0 per 1000 persons), is Crete, whose death rate has been at this level since at least 1930. [73] The diet of Crete is archetypical of the ‘traditional’ Greek diet before the introduction of continental European and American foods into Greece after ~ 1960.

The Seven Countries Study was the first to generate robust data on the incidence of cardiovascular disease in a range of populations (US, Finland, The Netherlands, Italy, the former Yugoslavia, Japan and Greece) with a fairly broad spectrum of dietary patterns. The study showed differences on the order of 5 to 10-fold in coronary artery disease (CAD) between the populations studied. [36, 50, 74]

Figure 2: The Cretan diet food pyramid.

Both the Seven Countries Study and the AHS-1 demonstrated large reductions in disease-specific morbidly and mortality, as well as in all-cause mortality; primarily as a result of diet and lifestyle differences. In the case of the Seven Countries Study, extensive follow-on research using well designed prospective studies, resulted in the development of a set of dietary guidelines which became known as the “Mediterranean” or more correctly, the “Cretan diet.” The guidelines which constitute the Cretan diet satisfy Level-1 EBM criteria for extension of the mean lifespan by ~10 years, reduction in all cause mortality, high levels of compliance, and very importantly, titratability. In other words, the degree of compliance with the diet is roughly commensurate with the benefit that results. [75-77]

What About Cholesterol?

For thirty years an acrimonious debate has raged in the scientific and medical communities over whether cholesterol, or any molecular species of lipoprotein, “causes heart disease” or other CVD. The causes of the inflammatory events that underlie the start of arterial plaque formations are complex, possibly multifactorial (e.g., genetic, viral, microbial, environmental, etc.) and by no means fully elucidated. Keys, Pritikin and many others mistakenly believed that “elevated” serum cholesterol was the primary cause of CVD. This hypothesis is well supported by the epidemiological data. However, there are many people who have normal or even slightly low levels of total cholesterol, or of the low density lipoprotein (LDL) species whose oxidation is usually cited as the motor of atherogenesis.

However, the observations of Keys and Pritkin extended beyond a cause and effect relationship between cholesterol and CVD. In different ways, both men demonstrated that altering the total serum cholesterol level and/or the ratio between the LDL and high density lipoprotein (HDL) species, they could reduce the incidence of the disease. In Pritkin’s case, he even demonstrated that the disease could be reversed by the expedient of a very low fat diet.[78-80] Pritkin demonstrated his theory on a very small population of people; principally those who read his book, or otherwise followed his dietary advice. Keys, on the other hand, conducted an experiment on a grand scale.

Throughout the 1960s Keys campaigned relentlessly to persuade physicians, public health authorities and the public themselves (directly) to replace the bulk of the calories they consumed in (saturated) fat with polyunsaturated fat. The purpose of this international dietary intervention was to reduce the serum cholesterol of the population, and thus the incidence of CVD. This effort enjoyed unprecedented success and it has resulted a doubling of the proportion of the unsaturated fatty acid, linoleic acid, in the tissues of Americans between 1960 and 1975.[81]  The mortality rate from coronary heart disease (CAD) in the US began to fall, starting in 1968, and it has continued to decline since then. It has been estimated that approximately 50% of the decline in CVD is as a result of dietary and lifestyle changes, exclusive of the reduction in tobacco abuse.[82]

As a scientist, I am acutely interested to understand the details of the pathophysiology of atherosclerosis. As someone who wants to avoid CVD, I am much more concerned with what works, even if the biomechanics are incomplete, or even contradictory. In this case, what works is that on a population basis, blood lipids are highly predictive of the risk of disease. Similarly, for most patients, raising HDL and lowering LDL are protective against both the onset of CVD, and to a lesser extent, its progression. Lipid status is thus a useful screening tool, as well as an instructive guide to the individual patient’s likely response to treatment. It is not necessary to believe that “cholesterol,” or any particular species of lipoprotein “causes” CVD. It is only necessary to understand that they are, at the least, useful biomarkers on a population wide basis and that they are often useful in the intelligent management of individual patients.

 Table 1: Fatty Acids Ratios in Different Diets

From the inception of the AHS-1 in 1958, and the Six Countries Study around the same time,[68, 83] the primary focus of the research, as was the case with Pritikin, was on the possible relationship of the diet to the etiology of CVD, with special emphasis on the fatty acid composition of the diet. The 5-year follow-up in the Seven Countries Study found favorable all-cause death rates in Greece, Italy and Japan, as compared with the other countries, including dramatically lower rates of CVD in Crete, and to a lesser extent in Japan.[84]The diet of Crete has in common with the diet of hunter-gatherers similar quantities of antioxidants, saturated fat, fiber, monounsaturated fat and, very importantly, the ratio of (n-6) to (n-3) fatty acids. [75-77]

One the basis of insights gained from the Seven Countries Study a wide range of epidemiologic investigations,  controlled clinical trials and relevant animal experiments have confirmed the hypotriglyceridemic, anti-inflammatory and antithrombotic aspects of (n-3) fatty acids (28 –35) as well as the criticality of (n-3) fatty acids, particularly Docosahexaenoic (n-3) (DHA) acid in the diet for the normal development of the retina and brain in the human infant. As a consequence of these insights, a study of the (n-3) fatty acid composition of diets that were known to be associated with reduced rates of CVD and cancer was undertaken.[75] The initial conclusion was that the high olive oil intake, which accounts for ~35% of the calories consumed in the Cretan diet, was likely responsible for the low rates of CVD and cancer. However, the Japanese have a similarly low incidence of these diseases and yet only ~11% of their calorie intake is from fat, none of which is from olive oil.

Figure 3: Mortality and morbidity difference between populations of patients with coronary artery disease (CAD) eating the Cretan diet and those on the low fat American Heart Association Step 1 diet[151]

The common factors between the populations of Crete and Japan were that they both consumed large amounts of vegetables (including wild plants), fruits, nuts and legumes, all of which are rich sources of folic acid, glutathione and vitamins E, C and other antioxidants. Wild plants are rich sources of (n-3) fatty acids and antioxidants and their consumption is not confined to humans. Both in Crete and in rural Japan, chickens and other livestock, such as goats and cows, are free ranging and consume wild vegetation in abundance (and in the case of chickens, insects, arachnids and worms) which are rich in (n-3) fatty acids and antioxidants, as well as cytoprotective and vasculoprotective trace minerals which are concentrated in the food chain. The result is poultry, eggs and milk which contain radically different ratios of (n-3) to (n-6) fatty acids and are enriched with selenium. For example, eggs from Crete have a ratio of (n-6) to (n-3) of 1:3, whereas the US ‘battery egg’ has a ratio of 19:4. Of course, the presence of this favorable ratio of lipids in eggs is also reflected in prepared foods which contain eggs (such as noodles, some breads and soups, etc.) and in the flesh of the animals that are slaughtered and eaten.

Analysis of the serum (n-3) fatty acid levels of the populations in Crete and Japan demonstrated that they had had higher concentrations of (n-3) fatty acids than did the other populations in the study, all of whom had a far high incidences of age associated degenerative diseases. The two populations with the lowest CAD in the Seven Countries Study consumed the highest amount of α-linoleic acid (α-LNA) the major sources of which were the wild herb purslane, walnuts and figs. By contrast, the Japanese obtained their α-LNA from canola and soybean oils. Interestingly, the Seventh Day Adventists, who experience an increase in mean lifespan of 7.28 years (95% confidence interval, 6.59-7.97 years) in men and by 4.42 years (95% confidence interval, 3.96-4.88 years) in women over that of their non-Adventist cohorts in the US[10], consume a vegetarian diet that is rich in nuts and oils containing α-LNA. The SDAs, like the people of Crete, have not only higher levels of α-LNA, but also lower levels of linoleic acid[9, 85, 86]

 

Figure 4: The Lyon Diet Heart Study demonstrated a 50 to 70% reduction of the risk of recurrence of myocardial infarction (MI) after four years of follow-up in coronary heart disease (CHD patients. The Lyon diet employed α-LNA as 0.6 to 1% of total daily energy or about 2 g per day in patients who follow a traditional Mediterranean diet. Supplementation with very long chain omega-3 fatty acids (c.1g per day) in patients following a Mediterranean type of diet was shown to decrease the risk of cardiac death by 30% and of sudden cardiac death by 45% in the GISSI trial. [87]

In 1994 de Lorgeril and Renaud published the results of a prospective study to evaluate a diet which contained the types and ratios of essential fatty acids (EFAs) found to be effective at reducing CVD in the Seven Countries Studies. The Lyon Heart Study (LHS), as it came to be known, was a randomized, single-blind secondary prevention trial that combined a modified Cretan diet enriched with α-LNA with that of the Step I American Heart Association diet.[87] The LHS demonstrated a reduction in all-cause mortality of 70% in the experimental population which consumed a diet low in butter and processed meats, but high in fish, nuts, fruits and vegetables (Figure 5).[87] The LHS followed subjects for 5 years after the start of the intervention and examined the reduction of risk for coronary artery disease (CAD) as well as in mortality from all cancers. The reduction in CAD was 56% (P 5 0.03) over that of control subjects, and in cancer mortality it was 61% (P 5 0.05)!

Figure 5: Cardiac morbidity and mortality in the Lyon Diet Heart Study. Of particular importance to cryonicists is the reduction in mortality from sudden cardiac death (SCD). [87]

Olive Oil, or Something Else?

Figure 6: The author has serious questions about whether experiments conducted using industrially prepared laboratory animal chows (right) are representative of the results obtained when fresh fruits and vegetable as well as foods consumed in their native state are used (left).

An initial and obvious conclusion from The Seven Countries Study was that a significant part of the reduction in morbidity and the extension of lifespan due to the Cretan diet was a consequence of the consumption of a large fraction of the calories in the diet in the form of monounsaturated  fats (MUFAs), principally as a result of olive oil consumption. However, recent animal studies have yielded paradoxical results. For instance, experiments in green monkeys have shown that a diet high in MUFAs (olive oil source) causes atherosclerosis equivalent to that observed in animals fed a diet high in saturated fats (SFAs).[88] This effect appears to result from an increased secretion of cholesteryl oleate enriched lipoproteins, as well as due to an increase in the circulating blood levels of chylomicron remnants, which are highly atherogenic lipoproteins. [89-91]

These paradoxical animal results have raised questions amongst epidemiologists and nutritionists about whether MUFAs really have beneficial effects in humans. Green monkeys are metabolically and genetically different than humans and the human data indicate that dietary MUFAs have favorable effects on CHD risk. There is also a significant amount of mechanistic data that indicate that there are molecular species in olive oil that have potent antioxidant and anti-inflammatory properties. In particular, the polyphenolic compounds hydroxytyrosol and oleuropein have been shown to possess these properties both in vitro and in vivo.[92-96] There is also the issue of the way in which olive oil is incorporated into the chow for experimental animals (Figure 6). Olive oil incorporated into a manufactured chow along with other dietary ingredients is not the way in which humans consume it, and this factor should be taken into consideration in future studies.

Figure 7: The titratability of the beneficial effects of the Cretan diet are nicely illustrated in this series of graphs showing all cause mortality over a ten year period with three variations of the Cretan diet; the world Health Organization recommended diet base on the Seven Countries Study, a broadly similar diet, and a carbohydrate restricted version of the Cretan Diet. Kaplan-Meier survival curves for individuals considered adequate reporters of dietary intake, grouped as low-, medium-, or high-adherent individuals to the dietary patterns investigated. Crude hazard ratios (HRs) and 95% CIs were calculated from Cox proportional hazards regression analyses with the use of low-adherent individuals as the reference group for each dietary pattern. A: World Health Organization (WHO) dietary guidelines, according to the Healthy Diet Indicator: medium adherent (HR: 0.70; 95% CI: 0.43, 1.15), high adherent (HR: 0.97; 95% CI: 0.45, 2.07). B: Mediterranean-like diet, according to the Mediterranean Diet Score: medium adherent (HR: 0.68; 95% CI: 0.44, 1.04), high adherent (HR: 0.29; 95% CI: 0.12, 0.70. C: Carbohydrate-restricted (CR) diet, according to the CR diet score: medium adherent (HR: 1.92; 95% CI: 1.02, 3.62), high adherent (HR: 2.17; 95% CI: 1.05, 4.45).[148]

Anti-inflammatory and Cytoregulatory Lipids in the Cretan Diet

One proposed resolution to the paradoxical animal findings regarding the atherogenicity of olive oil in the laboratory is the observation that both the high fat MFA diet of the Cretans, and the low fat PFA diet of the Japanese, are rich in (n-3) fatty acids and antioxidants, in particular resveratrol, glutathione, vitamin C, vitamin E, lycopene, b-carotene, polyphenols and polyamines obtained from fruits, vegetables, wild plants, and olive oil. [97] [98-101] Additionally, both diets are enriched in α-LNA and eicosapentaenoic acid [EPA, 20:5 (n-3)] from the consumption of large amounts of fish, relative to the control countries.[159, 171, 174] Because olive oil is high in the monounsaturated fatty acid oleic acid [18:1, (n-9)] and low in saturated (n-6) fatty acids it cannot compete with the endogenous desaturation and elongation of α-LNA, or with the incorporation of α-LNA into the constituent phospholipids of cell membranes. This is particularly important in the case of red blood cell (RBC) and platelet membranes, where they act to increase the deformability of RBCs and decrease the aggreability and adhesions of platelets. [102-108]

The ratio of (n-6) to (n-3) lipids in the Cretan diet is between 2:1 and 1:1, which is very close to the dietary ratio of the Japanese, as that of hunter-gatherer societies. The beneficial effects of such a ratio and their importance in normal growth and development [109, 110] as well as in the reduction of risk for CVD, hypertension, type II diabetes, osteoarthritis and, to a lesser extent cancer, are voluminously documented in the literature.[111] [112-116] The traditional Greek diet is very low in animal fat and thus the saturated fat content is quite low (7–8%). This low intake of SFAs is complemented by the high intake of  (n-6) and (n-3) EFAs which are also rich in phytoestrogens and other phytochemicals  as well α-LNA, vitamin C, vitamin E and glutathione.[117, 118] These molecules have been shown to have hypoglycemic, hypocholesterolemic and antitumor properties in animal experiments.[119-124] Consistent with these findings is the fact that the mortality from breast, prostate, bladder and colorectal cancer is lower in both the Cretan and the AHS populations than is the case for controls. [14, 20, 86, 125-129]

The principal EFA in the US diet is LA, an (n-6) fatty acid which is the precursor to the eicosanoids – molecules which have proinflammatory and cytoproliferative effects. The EFAs are converted to prostaglandins by the cyclooxygenases and to leukotrienes (LT) by the lipoxygenases. Arachidonicacid [(AA); 20:4(n-6)] and EPA, an (n-3) fatty acid, compete for cyclooxygenases and lipoxygenases, resulting in the production of eicosanoids with opposing effects. In general, AA-derived eicosanoids, such as the 2-series prostanoids and 4-series LTs, have pro-inflammatory effects, whereas EPA-derived eicosanoids, such as the 3-series prostanoids and5-series LTs, have anti-inflammatory effects. A focus of recent research has been to understand the importance of the (n-6) to (n-3) ratio, rather than the absolute level of either species of PUFA in cancer prevention.[102, 130]

Figure 8: The major active product of the omega-6 fatty acids is arachadonic acid which is converted to the 2-series prostaglandins and 4-series leukotrienes by the action of cyclooxygenase. The 2-series prostaglandins are pro-inflammatory.  In addition to the AA produced endogenously there are vast supplies available from the diet, most notably in meat, eggs and peanut oil.  In the Western diet there are comparatively few products of omega-3 metabolism to moderate the pro-inflammatory action of excessive dietary omega-6consumption. If the amount of omega-3 fatty acids in the diet is increased, their metabolites (primarily EPA and DHA) compete with arachidonic acid for access to cyclooxygenase resulting increased production of anti-inflammatory mediators as well as a decrease in the pro-inflammatory mediators, thereby significantly reducing the ratio of pro-inflammatory to anti-inflammatory mediators.

In animal studies (rats) LA increases the size and number of tumors, whereas fish oil [containing the (n-3) fatty acids EPA and DHA] decreases the incidence of tumor formation, as well as tumor size.[131] This finding is consistent with other studies in rats that indicate that the potent inhibitors of prostaglandin synthesis, the NSAIDs indomethacin and flurbiprofen are effective at reducing the incidence of spontaneously occurring breast cancer. Epidemiological studies in humans have also indicated a potentially chemoprotective effect as result of long term consumption of NSAID drugs.[132-136] Fish oils have been used to adjust systemic levels of  (n-3) fatty acids in animals models of colon, lung, breast, pancreatic and prostate cancers to reduce prostaglandin synthesis, with resulting chemoprevrention and/or slowed growth and metastases in neoplastic disease in the laboratory setting.[131]

These studies, together with the epidemiologic evidence, appear to confirm the importance of a (n-6) to (n-3) ratio of 2:1 as being chemoprotective in cancer, and raise the possibility that (n-3) fatty acids might be used as adjuvant therapy to reduce the risk of recurrence and metastases of breast cancer in humans following surgery and chemotherapy.[132-136] Epidemiological studies have also consistently shown that fish oil consumption protects against the development of a broad range of cancers, but especially breast and prostate cancer. [137-144] Thus, it is not the absolute level of either (n-3) or (n-6) lipids, but rather their presence in a ratio of 1:1 or 2:1 that chemoprotective against a number of cancers[128, 129, 145, 146] Western diets have a ratio of 10–20:1.[147]

Figure 9: The Cretan diet provides significant protection against Alzheimer’s disease (AD) in patients who have been diagnosed with mild cognitive impairment (MCI). Survival curves based on Cox analysis comparing cumulative AD incidence in subjects with MCI at the first evaluation by Mediterranean diet (MeDi) adherence tertile (P for trend = .02). The figure is derived from a model that is adjusted for cohort, age, sex, ethnicity, education, APOE genotype, caloric intake, body mass index, and time between the first dietary assessment and the first cognitive assessment. Duration of follow-up is truncated at 10 years. Results of log-rank tests for pairwise comparisons are as follows: middle vs low tertile, 2 = 4.26, P = .03; low vs high tertile, 2 = 1.39, P = .23; and middle vs high tertile, 2 = 0.12, P = .72.[148, 149]

Both the Cretan and the Adventist vegetarian diets confer substantial protection against the mild cognitive impairment (MCI) of aging and against Alzheimer’s disease (AD)(Figure 9)[148, 149] Interestingly, the AHS-2 results demonstrate a link between the incidence of dementia and the consumption of all meat products, including fish and poultry. This may account for added benefit of Adventist Vegetarian diet over what would be expected on the basis of its lipid constituents and the presence of some adverse foodstuffs, such as refined sugar. Perhaps meat consumption is associated with adverse effects, per se? The literature is open to interpretation on this point.[150, 151]

The two highest quality studies examining the effect of vegetarian diets on lifespan, as well as morbidity were conducted by Key, et al., and were published in 2009.[152, 153] These studies found no significant difference in lifespan between the control and the vegetarian populations in the study. However, as so often happens in studies of this kind, both the control and the vegetarian group experienced statistically significant lower rates of mortality than the general population (UK). This kind of confounding result may be due to self-selection of on average healthier people within the general population to serve as controls. Another limitation on these studies is that they were barely powered adequately to detect small to moderate differences in mortality. The vegetarian group in this study had a lower body mass index (BMI) and consequently less obesity. The incidence of CVD and cancer were not statistically significant between the groups.

End of Part 2

References

1.            Gottlieb SH: “K-ration”. Diabetes and cardiovascular risk. Diabetes Forecast 2002, 55(2):44-46.

2.            Kalm LM, Semba RD: They starved so that others be better fed: remembering Ancel Keys and the Minnesota experiment. J Nutr 2005, 135(6):1347-1352.

3.            Keys A, Taylor HL, Blackburn H, Brozek J, Anderson JT, Simonson E: Coronary Heart Disease among Minnesota Business and Professional Men Followed Fifteen Years. Circulation 1963, 28:381-395.

4.            Skinner JD, Carruth BR, Pope J, Varner L, Goldberg D: Food and nutrient intake of white, pregnant adolescents. J Am Diet Assoc 1992, 92(9):1127-1129.

5.            Grundmann E: Cancer morbidity and mortality in USA Mormons and Seventh-day Adventists. Arch Anat Cytol Pathol 1992, 40(2-3):73-78.

6.            Fraser GE: Associations between diet and cancer, ischemic heart disease, and all-cause mortality in non-Hispanic white California Seventh-day Adventists. Am J Clin Nutr 1999, 70(3 Suppl):532S-538S.

7.            Fraser GE: Determinants of ischemic heart disease in Seventh-day Adventists: a review. Am J Clin Nutr 1988, 48(3 Suppl):833-836.

8.            Fraser GE, Lindsted KD, Beeson WL: Effect of risk factor values on lifetime risk of and age at first coronary event. The Adventist Health Study. Am J Epidemiol 1995, 142(7):746-758.

9.            Fraser GE, Sabate J, Beeson WL, Strahan TM: A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study. Arch Intern Med 1992, 152(7):1416-1424.

10.          Fraser GE, Shavlik DJ: Ten years of life: Is it a matter of choice? Arch Intern Med 2001, 161(13):1645-1652.

11.          Fraser GE, Shavlik DJ: Risk factors for all-cause and coronary heart disease mortality in the oldest-old. The Adventist Health Study. Arch Intern Med 1997, 157(19):2249-2258.

12.          Giem P, Beeson WL, Fraser GE: The incidence of dementia and intake of animal products: preliminary findings from the Adventist Health Study. Neuroepidemiology 1993, 12(1):28-36.

13.          Mills PK, Beeson WL, Phillips RL, Fraser GE: Cancer incidence among California Seventh-Day Adventists, 1976-1982. Am J Clin Nutr 1994, 59(5 Suppl):1136S-1142S.

14.          Singh PN, Sabate J, Fraser GE: Does low meat consumption increase life expectancy in humans? Am J Clin Nutr 2003, 78(3 Suppl):526S-532S.

15.          Snowdon DA, Phillips RL, Fraser GE: Meat consumption and fatal ischemic heart disease. Prev Med 1984, 13(5):490-500.

16.          Mills PK, Preston-Martin S, Annegers JF, Beeson WL, Phillips RL, Fraser GE: Risk factors for tumors of the brain and cranial meninges in Seventh-Day Adventists. Neuroepidemiology 1989, 8(5):266-275.

17.          Singh N, Graves J, Taylor PD, MacAllister RJ, Singer DR: Effects of a ‘healthy’ diet and of acute and long-term vitamin C on vascular function in healthy older subjects. Cardiovasc Res 2002, 56(1):118-125.

18.          Taylor CB, Allen ES, Mikkelson B, Kang-Jey H: Serum cholesterol levels of Seventh-day Adventists. Paroi Arterielle 1976, 3(4):175-179.

19.          Kahn HA, Phillips RL, Snowdon DA, Choi W: Association between reported diet and all-cause mortality. Twenty-one-year follow-up on 27,530 adult Seventh-Day Adventists. Am J Epidemiol 1984, 119(5):775-787.

20.          Beeson WL, Mills PK, Phillips RL, Andress M, Fraser GE: Chronic disease among Seventh-day Adventists, a low-risk group. Rationale, methodology, and description of the population. Cancer 1989, 64(3):570-581.

21.          Masley SC, Weaver W, Peri G, Phillips SE: Efficacy of lifestyle changes in modifying practical markers of wellness and aging. Altern Ther Health Med 2008, 14(2):24-29.

22.          Mills PK, Annegers JF, Phillips RL: Animal product consumption and subsequent fatal breast cancer risk among Seventh-day Adventists. Am J Epidemiol 1988, 127(3):440-453.

23.          Phillips RL, Garfinkel L, Kuzma JW, Beeson WL, Lotz T, Brin B: Mortality among California Seventh-Day Adventists for selected cancer sites. J Natl Cancer Inst 1980, 65(5):1097-1107.

24.          Phillips RL, Snowdon DA: Dietary relationships with fatal colorectal cancer among Seventh-Day Adventists. J Natl Cancer Inst 1985, 74(2):307-317.

25.          Vang A, Singh PN, Lee JW, Haddad EH, Brinegar CH: Meats, processed meats, obesity, weight gain and occurrence of diabetes among adults: findings from Adventist Health Studies. Ann Nutr Metab 2008, 52(2):96-104.

26.          Fonnebo V: The Tromso Heart Study: coronary risk factors in Seventh-Day Adventists. Am J Epidemiol 1985, 122(5):789-793.

27.          Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S et al: Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 1995, 155(4):381-386.

28.          Coronary heart disease in seven countries. I. The study program and objectives. Circulation 1970, 41(4 Suppl):I1-8.

29.          Twenty-five year incidence and prediction of coronary heart disease in two Italian rural population samples. The Italian Research Group of the Seven Countries Study. Acta Cardiol 1986, 41(4):283-299.

30.          The diet and all-causes death rate in the Seven Countries Study. Lancet 1981, 2(8237):58-61.

31.          Alberti-Fidanza A, Fidanza F, Chiuchiu MP, Verducci G, Fruttini D: Dietary studies on two rural italian population groups of the Seven Countries Study. 3. Trend Of food and nutrient intake from 1960 to 1991. Eur J Clin Nutr 1999, 53(11):854-860.

32.          Alberti-Fidanza A, Paolacci CA, Chiuchiu MP, Coli R, Fruttini D, Verducci G, Fidanza F: Dietary studies on two rural Italian population groups of the Seven Countries Study. 1. Food and nutrient intake at the thirty-first year follow-up in 1991. Eur J Clin Nutr 1994, 48(2):85-91.

33.          Alberti-Fidanza A, Paolacci CA, Chiuchiu MP, Coli R, Parretta MG, Verducci G, Fidanza F: Dietary studies on two rural Italian population groups of the Seven Countries Study. 2. Concurrent validation of protein, fat and carbohydrate intake. Eur J Clin Nutr 1994, 48(2):92-96.

34.          Alonso A, Jacobs DR, Jr., Menotti A, Nissinen A, Dontas A, Kafatos A, Kromhout D: Cardiovascular risk factors and dementia mortality: 40 years of follow-up in the Seven Countries Study. J Neurol Sci 2009, 280(1-2):79-83.

35.          Alvarez Guisasola F, Mavros P, Nocea G, Alemao E, Alexander CM, Yin D: Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study. Diabetes Obes Metab 2008, 10 Suppl 1:8-15.

36.          Cheng TO: Ancel Keys, seven countries study, China connections, and K rations. J Am Diet Assoc 2005, 105(3):349.

37.          de Lorgeril M, Salen P: Mediterranean type of diet for the prevention of coronary heart disease. A global perspective from the seven countries study to the most recent dietary trials. Int J Vitam Nutr Res 2001, 71(3):166-172.

38.          Ducimetiere P, Richard JL, Cambien F, Rakotovao R, Claude JR: Coronary heart disease in middle-aged Frenchmen. Comparisons between Paris Prospective Study, Seven Countries Study, and Pooling Project. Lancet 1980, 1(8182):1346-1350.

39.          Farchi G, Fidanza F, Giampaoli S, Mariotti S, Menotti A: Alcohol and survival in the Italian rural cohorts of the Seven Countries Study. Int J Epidemiol 2000, 29(4):667-671.

40.          Feskens EJ, Tuomilehto J, Stengard JH, Pekkanen J, Nissinen A, Kromhout D: Hypertension and overweight associated with hyperinsulinaemia and glucose tolerance: a longitudinal study of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetologia 1995, 38(7):839-847.

41.          Feskens EJ, Virtanen SM, Rasanen L, Tuomilehto J, Stengard J, Pekkanen J, Nissinen A, Kromhout D: Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetes Care 1995, 18(8):1104-1112.

42.          Fidanza F, Alberti A, Lanti M, Menotti A: Mediterranean diet score: correlation with 25-year mortality from coronary heart disease in the Seven Countries Study. Nutr Metab Cardiovasc Dis 2004, 14(6):397.

43.          Alberti A, Fruttini D, Fidanza F: The Mediterranean Adequacy Index: further confirming results of validity. Nutr Metab Cardiovasc Dis 2009, 19(1):61-66.

44.          Jacobs DR, Jr., Adachi H, Mulder I, Kromhout D, Menotti A, Nissinen A, Blackburn H: Cigarette smoking and mortality risk: twenty-five-year follow-up of the Seven Countries Study. Arch Intern Med 1999, 159(7):733-740.

45.          Jansen DF, Nedeljkovic S, Feskens EJ, Ostojic MC, Grujic MZ, Bloemberg BP, Kromhout D: Coffee consumption, alcohol use, and cigarette smoking as determinants of serum total and HDL cholesterol in two Serbian cohorts of the Seven Countries Study. Arterioscler Thromb Vasc Biol 1995, 15(11):1793-1797.

46.          Jansen MC, Bueno-de-Mesquita HB, Buzina R, Fidanza F, Menotti A, Blackburn H, Nissinen AM, Kok FJ, Kromhout D: Dietary fiber and plant foods in relation to colorectal cancer mortality: the Seven Countries Study. Int J Cancer 1999, 81(2):174-179.

47.          Jansen MC, Bueno-de-Mesquita HB, Rasanen L, Fidanza F, Menotti A, Nissinen A, Feskens EJ, Kok FJ, Kromhout D: Consumption of plant foods and stomach cancer mortality in the seven countries study. Is grain consumption a risk factor? Seven Countries Study Research Group. Nutr Cancer 1999, 34(1):49-55.

48.          Kafatos A, Diacatou A, Voukiklaris G, Nikolakakis N, Vlachonikolis J, Kounali D, Mamalakis G, Dontas AS: Heart disease risk-factor status and dietary changes in the Cretan population over the past 30 y: the Seven Countries Study. Am J Clin Nutr 1997, 65(6):1882-1886.

49.          Karon JM, Parker RA: Re: “The diet and 15-year death rate in the Seven Countries Study”. Am J Epidemiol 1988, 128(1):238-241.

50.          Keys A, Menotti A, Aravanis C, Blackburn H, Djordevic BS, Buzina R, Dontas AS, Fidanza F, Karvonen MJ, Kimura N et al: The seven countries study: 2,289 deaths in 15 years. Prev Med 1984, 13(2):141-154.

51.          Kromhout D: [The 'Seven Countries Study': 40 years of research in coronary heart diseases in 7 countries]. Ned Tijdschr Geneeskd 1997, 141(1):7-9.

52.          Kromhout D, Bloemberg B, Feskens E, Menotti A, Nissinen A: Saturated fat, vitamin C and smoking predict long-term population all-cause mortality rates in the Seven Countries Study. Int J Epidemiol 2000, 29(2):260-265.

53.          Kromhout D, Bloemberg B, Seidell JC, Nissinen A, Menotti A: Physical activity and dietary fiber determine population body fat levels: the Seven Countries Study. Int J Obes Relat Metab Disord 2001, 25(3):301-306.

54.          Kromhout D, Katan MB, Menotti A, Keys A, Bloemberg B: Serum cholesterol and long-term death rates from suicide, accidents, or violence. Seven Countries Study Group. Lancet 1992, 340(8814):317.

55.          Kromhout D, Menotti A, Bloemberg B, Aravanis C, Blackburn H, Buzina R, Dontas AS, Fidanza F, Giampaoli S, Jansen A et al: Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev Med 1995, 24(3):308-315.

56.          Kromhout D, Nedeljkovic SI, Grujic MZ, Ostojic MC, Keys A, Menotti A, Katan MB, van Oostrom MA, Bloemberg BP: Changes in major risk factors for cardiovascular diseases over 25 years in the Serbian cohorts of the Seven Countries Study. Int J Epidemiol 1994, 23(1):5-11.

57.          Lanti M, Menotti A, Nedeljkovic S, Nissinen A, Kafatos A, Kromhout D: Long-term trends in major cardiovascular risk factors in cohorts of aging men in the European cohorts of the Seven Countries Study. Aging Clin Exp Res 2005, 17(4):306-315.

58.          Mamalakis G, Jansen E, Cremers H, Kiriakakis M, Tsibinos G, Kafatos A: Depression and adipose and serum cholesteryl ester polyunsaturated fatty acids in the survivors of the seven countries study population of Crete. Eur J Clin Nutr 2006, 60(8):1016-1023.

59.          Mamalakis G, Kiriakakis M, Tsibinos G, Kafatos A: Depression and adipose polyunsaturated fatty acids in the survivors of the Seven Countries Study population of Crete. Prostaglandins Leukot Essent Fatty Acids 2004, 70(6):495-501.

60.          Mariotti S, Capocaccia R, Farchi G, Menotti A, Verdecchia A, Keys A: Differences in the incidence rate of coronary heart disease between north and south European cohorts of the Seven Countries Study as partially explained by risk factors. Eur Heart J 1982, 3(5):481-487.

61.          Mariotti S, Capocaccia R, Farchi G, Menotti A, Verdecchia A, Keys A: Age, period, cohort and geographical area effects on the relationship between risk factors and coronary heart disease mortality. 15-year follow-up of the European cohorts of the Seven Countries study. J Chronic Dis 1986, 39(3):229-242.

62.          Menotti A: The relationship of total serum cholesterol to coronary heart disease in older men. The Italian rural areas of the Seven Countries Study. Ann Epidemiol 1992, 2(1-2):107-111.

63.          Menotti A, Blackburn H, Kromhout D, Nissinen A, Adachi H, Lanti M: Cardiovascular risk factors as determinants of 25-year all-cause mortality in the seven countries study. Eur J Epidemiol 2001, 17(4):337-346.

64.          Menotti A, Blackburn H, Kromhout D, Nissinen A, Karvonen M, Aravanis C, Dontas A, Fidanza F, Giampaoli S: The inverse relation of average population blood pressure and stroke mortality rates in the seven countries study: a paradox. Eur J Epidemiol 1997, 13(4):379-386.

65.          Menotti A, Blackburn H, Seccareccia F, Kromhout D, Nissinen A, Aravanis C, Giampaoli S, Mohacek I, Nedeljkovic S, Toshima H: The relation of chronic diseases to all-cause mortality risk–the Seven Countries Study. Ann Med 1997, 29(2):135-141.

66.          Menotti A, Conti S, Corradini P, Giampaoli S, Rumi A, Signoretti P: [Incidence and prediction of coronary heart disease in the Italian cohorts of the Seven Countries Study. 10 year experience (author's transl)]. G Ital Cardiol 1980, 10(7):792-806.

67.          Menotti A, Jacobs DR, Jr., Blackburn H, Kromhout D, Nissinen A, Nedeljkovic S, Buzina R, Mohacek I, Seccareccia F, Giampaoli S et al: Twenty-five-year prediction of stroke deaths in the seven countries study: the role of blood pressure and its changes. Stroke 1996, 27(3):381-387.

68.          Menotti A, Keys A, Aravanis C, Blackburn H, Dontas A, Fidanza F, Karvonen MJ, Kromhout D, Nedeljkovic S, Nissinen A et al: Seven Countries Study. First 20-year mortality data in 12 cohorts of six countries. Ann Med 1989, 21(3):175-179.

69.          Menotti A, Keys A, Blackburn H, Aravanis C, Dontas A, Fidanza F, Giampaoli S, Karvonen M, Kromhout D, Nedeljkovic S et al: Twenty-year stroke mortality and prediction in twelve cohorts of the Seven Countries Study. Int J Epidemiol 1990, 19(2):309-315.

70.          Menotti A, Keys A, Blackburn H, Karvonen M, Punsar S, Nissinen A, Pekkanen J, Kromhout D, Giampaoli S, Seccareccia F et al: Blood pressure changes as predictors of future mortality in the seven countries study. J Hum Hypertens 1991, 5(3):137-144.

71.          Menotti A, Keys A, Blackburn H, Kromhout D, Karvonen M, Nissinen A, Pekkanen J, Punsar S, Fidanza F, Giampaoli S et al: Comparison of multivariate predictive power of major risk factors for coronary heart diseases in different countries: results from eight nations of the Seven Countries Study, 25-year follow-up. J Cardiovasc Risk 1996, 3(1):69-75.

72.          Menotti A, Keys A, Kromhout D, Blackburn H, Aravanis C, Bloemberg B, Buzina R, Dontas A, Fidanza F, Giampaoli S et al: Inter-cohort differences in coronary heart disease mortality in the 25-year follow-up of the seven countries study. Eur J Epidemiol 1993, 9(5):527-536.

73.          Allbaugh L: Crete: A Case Study of an Underdeveloped Area. Princeton, N.J: Princeton University Press; 1953.

74.          Keys A, Menotti A, Karvonen MJ, Aravanis C, Blackburn H, Buzina R, Djordjevic BS, Dontas AS, Fidanza F, Keys MH et al: The diet and 15-year death rate in the seven countries study. Am J Epidemiol 1986, 124(6):903-915.

75.          Simopoulos A, Robinson, J.: The Omega Diet. The Lifesaving Nutritional Program Based on the Diet of the Island of Crete. New York: HarperCollins; 1999.

76.          Simopoulos AP: The traditional diet of Greece and cancer. Eur J Cancer Prev 2004, 13(3):219-230.

77.          Simopoulos AP: What is so special about the diet of Greece? The scientific evidence. World Rev Nutr Diet 2005, 95:80-92.

78.          Ornish D: Can lifestyle changes reverse coronary heart disease? World Rev Nutr Diet 1993, 72:38-48.

79.          Hubbard J, Inkeles, S, Barnard, RJ.: Nathan Pritikin’s Heart. N Engl J Med 1985, 313:52.

80.          Barnard R, Pritikin, R,  Rosenthal, R, et al.: Pritikin Approach to Cardiac Rehabilitation; Rehabilitation Medicine. St. Louis: Mosby Company, ; 1988.

81.          Katan M, Beynen, AC.: Linoleic acid consumption and coronary heart disease  in U.S.A. and U.K. Lancet 1981, 15(2(8242)):371.

82.          Goldman L, Cook, EF.: The decline in ischemic heart disease mortality rates: An analysis of the comparative effects of medical interventions and changes in lifestyle. . Ann Intern Med 1984 101(6)::825-836.

83.          Keys A: Coronary heart disease in seven countries. Circulation

 1970, 41: (suppl.): 1-211

 

84.          Keyes A: Coronary heart disease in seven countries. Circulation

 1970, 41: (suppl.): 1-211

 

85.          Sandker GW, Kromhout, D, Aravanis, C, Bloemberg, BP. Mensink, R P, Karalias, N, Katan, MB.: Serum lipids in elderly men in Crete and The Netherlands. . Eur J Clin Nutr 1993, 47:201-208.

86.          Willett W: Lessons from dietary studies in Adventists and questions for the future. Am J Clin Nutr 2003, 78(3 Suppl):539S-543S.

87.          de Lorgeril M, Salen P: The Mediterranean diet in secondary prevention of coronary heart disease. Clin Invest Med 2006, 29(3):154-158.

88.          Rudel L, Parks, JS,  Sawyer, JK.: Compared with dietary monounsaturated and saturated fat, polyunsaturated fat protects african green monkeys from coronary artery atherosclerosis Arteriosclerosis, Thrombosis, and Vascular Biology 1995, 15:2101-2110

89.          Higashi K, Ishikawa, T, Shige H, Tomiyasu, K, Yoshida, H, Ito, T, Nakajima, K, Yonemura, A, Sawada, S, Nakamura, H.: Olive oil increases the magnitude of postprandial chylomicron remnants compared to milk fat and safflower oil. J Am Coll Nutr 1997, 16::429-434.

90.          de Bruin T, Brouwer, CB, van Linde-Sibenius, TM, Erkelens,DW. : Different postprandial metabolism of olive oil and soybean oil: a possible mechanism of the high-density lipoprotein conserving effect of olive oil. Am J Clin Nutr 1993, 58:477-483.

91.          Bray G, Popkin, BM. : Dietary fat intake does affect obesity. Am J Clin Nutr 1998, 68:1157-1173.

92.          Briante R, Febbraio F, Nucci R: Antioxidant properties of low molecular weight phenols present in the mediterranean diet. J Agric Food Chem 2003, 51(24):6975-6981.

93.          Boskou D: Olive oil. World Rev Nutr Diet 2007, 97:180-210.

94.          Konstantinidou V, Covas MI, Munoz-Aguayo D, Khymenets O, de la Torre R, Saez G, Tormos Mdel C, Toledo E, Marti A, Ruiz-Gutierrez V et al: In vivo nutrigenomic effects of virgin olive oil polyphenols within the frame of the Mediterranean diet: a randomized controlled trial. FASEB J, 24(7):2546-2557.

95.          Wahle KW, Caruso D, Ochoa JJ, Quiles JL: Olive oil and modulation of cell signaling in disease prevention. Lipids 2004, 39(12):1223-1231.

96.          Battino M, Ferreiro MS: Ageing and the Mediterranean diet: a review of the role of dietary fats. Public Health Nutr 2004, 7(7):953-958.

97.          Manios Y, Detopoulou V, Visioli F, Galli C: Mediterranean diet as a nutrition education and dietary guide: misconceptions and the neglected role of locally consumed foods and wild green plants. Forum Nutr 2006, 59:154-170.

98.          Ferro-Luzzi A, James WP, Kafatos A: The high-fat Greek diet: a recipe for all? Eur J Clin Nutr 2002, 56(9):796-809.

99.          Renaud S, de Lorgeril, M., Delaye, J., Guidollet, J., Jacquard, F., Mamelle, N., Martin, J. L., Monjaud, I., Salen, P, Touboul, P.: Cretan

Mediterranean diet for prevention of coronary heart disease. Am J Clin Nutr 1995, 61((suppl.)):1360S-1367S.

100.        Mamelle N: Mediterranean dietary pattern in a randomized trial. Prolonged survival and possible reduced cancer rate. Arch Intern Med 1998, 158:1181-1187.

101.        de Lorgeril M, Salen P: Modified cretan Mediterranean diet in the prevention of coronary heart disease and cancer: An update. World Rev Nutr Diet 2007, 97:1-32.

102.        Simopoulos A: Omega-3 fatty acids in health and disease and in growth and development. m J Clin Nutr 1991(54):438-463.

103.        Freese R, Mutanen M, Valsta LM, Salminen I: Comparison of the effects of two diets rich in monounsaturated fatty acids differing in their linoleic/alpha-linolenic acid ratio on platelet aggregation. Thromb Haemost 1994, 71(1):73-77.

104.        Valsta LM, Salminen I, Aro A, Mutanen M: Alpha-linolenic acid in rapeseed oil partly compensates for the effect of fish restriction on plasma long chain n-3 fatty acids. Eur J Clin Nutr 1996, 50(4):229-235.

105.        Sebedio JL, Vermunt SH, Chardigny JM, Beaufrere B, Mensink RP, Armstrong RA, Christie WW, Niemela J, Henon G, Riemersma RA: The effect of dietary trans alpha-linolenic acid on plasma lipids and platelet fatty acid composition: the TransLinE study. Eur J Clin Nutr 2000, 54(2):104-113.

106.        Garcia-Marcos L, Canflanca IM, Garrido JB, Varela AL, Garcia-Hernandez G, Guillen Grima F, Gonzalez-Diaz C, Carvajal-Uruena I, Arnedo-Pena A, Busquets-Monge RM et al: Relationship of asthma and rhinoconjunctivitis with obesity, exercise and Mediterranean diet in Spanish schoolchildren. Thorax 2007, 62(6):503-508.

107.        Burri BJ, Dougherty RM, Kelley DS, Iacono JM: Platelet aggregation in humans is affected by replacement of dietary linoleic acid with oleic acid. Am J Clin Nutr 1991, 54(2):359-362.

108.        Chan JK, McDonald BE, Gerrard JM, Bruce VM, Weaver BJ, Holub BJ: Effect of dietary alpha-linolenic acid and its ratio to linoleic acid on platelet and plasma fatty acids and thrombogenesis. Lipids 1993, 28(9):811-817.

109.        Birch E, Hoffman, DR, Uauy, R, Birch, DG, Prestidge, C.: Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. Pediatr Res 1998, 44: 201-209.

110.        Birch E, Birch, D., Hoffman, D., Hale, L., Everett, M, Uauy, R.: Breast-feeding and optimal visual development Strabismus

  J Pediatr Ophthalmol 1993, 30: 33-38.

111.        Simopoulos A, Kifer, RR, Martin, RE.: Health  effects of polyunsaturated fatty acids in seafoods. Orlando: Academic Press; 1986.

112.        Hamazaki T, Okuyama, H. (ed.): Fatty Acids and Lipids-New Findings: http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=224409. Basel: Karger; 2001.

113.        Leaf A, Weber, PC.: Cardiovascular effects of n-3 fatty acids. N Engl J Med 1988, 318:549-557.

114.        Simopoulos A: Fatty acids in the prevention-management of cardiovascular disease. Can J Physiol Pharmacol 1997, 75:234-239.

115.        Simopoulos A: Essential fatty acids in health and chronic disease. Am J Clin Nutr 1999, 70 ( (suppl.)):560S-569S.

116.        Simopoulos A, Leaf, A, Salem, N., Jr.: Essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Ann Nutr Metabolism 1999, 43:27-130.

117.        Weisburger J: Mechanisms of action in antioxidants as exemplified in vegetables, tomatoes and tea. Food Chem Toxicol 1999, 37(943-948).

118.        Hertog M, Hollman,  PCH, Katan, MB.: Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in The Netherlands. J Agric Food Chem 1992, 40:2379-2383.

119.        Slater T, Block, G,  eds.: Antioxidant vitamins and b-carotene in disease prevention. Am J Clin Nutr 1991, 53( (suppl.)):189S-396S.

120.        Agradi E, Vegeto E, Sozzi A, Fico G, Regondi S, Tome F: Traditional healthy Mediterranean diet: estrogenic activity of plants used as food and flavoring agents. Phytother Res 2006, 20(8):670-675.

121.        Gerber M: Biofactors in the Mediterranean diet. Clin Chem Lab Med 2003, 41(8):999-1004.

122.        Heinrich M, Leonti M, Nebel S, Peschel W: “Local Food – Nutraceuticals”: an example of a multidisciplinary research project on local knowledge. J Physiol Pharmacol 2005, 56 Suppl 1:5-22.

123.        Visioli F, Galli C: Biological properties of olive oil phytochemicals. Crit Rev Food Sci Nutr 2002, 42(3):209-221.

124.        Cristina F: Mediterranean diet health benefits may be due to a synergistic combination of phytochemicals and fatty-acids. BMJ 2005, 331(7508):E366.

125.        Mills PK, Beeson WL, Phillips RL, Fraser GE: Bladder cancer in a low risk population: results from the Adventist Health Study. Am J Epidemiol 1991, 133(3):230-239.

126.        Hirayama T: Mortality in Japanese with life-styles similar to Seventh-Day Adventists: strategy for risk reduction by life-style modification. Natl Cancer Inst Monogr 1985, 69:143-153.

127.        Zollinger TW, Phillips RL, Kuzma JW: Breast cancer survival rates among Seventh-day Adventists and non-Seventh-day Adventists. Am J Epidemiol 1984, 119(4):503-509.

128.        Levi F, La Vecchia, C, Lucchini, F, Negri, E.: Cancer mortalityin Europe. Eur J Cancer Prev 1995, 1990-1992(4):389-417.

129.        Stamatiou K, Alevizos A, Mariolis A, Sofras F: [Mediterranean diet and prostate cancer]. Actas Urol Esp 2006, 30(3):340.

130.        Fernandez E, Gallus S, La Vecchia C: Nutrition and cancer risk: an overview. J Br Menopause Soc 2006, 12(4):139-142.

131.        Cave W, Jr.: Fatty acid diet effects on tumorigenesis in experimental animals. . World Rev Nutr Diet 1991, 3(66):462-476.

132.        Cowing B, Saker, KE.: Polyunsaturated fatty acids and epidermal growth factor receptor/mitogen-activated protein kinase signaling in

mammary cancer. J Nutr 2001, 131::1125-1128.

133.        Schley PD, Brindley DN, Field CJ: (n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells. J Nutr 2007, 137(3):548-553.

134.        Ge Y, Chen Z, Kang ZB, Cluette-Brown J, Laposata M, Kang JX: Effects of adenoviral gene transfer of C. elegans n-3 fatty acid desaturase on the lipid profile and growth of human breast cancer cells. Anticancer Res 2002, 22(2A):537-543.

135.        Bardon S, Le MT, Alessandri JM: Metabolic conversion and growth effects of n-6 and n-3 polyunsaturated fatty acids in the T47D breast cancer cell line. Cancer Lett 1996, 99(1):51-58.

136.        Chajes V, Sattler W, Stranzl A, Kostner GM: Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: relationship to peroxides and vitamin-E. Breast Cancer Res Treat 1995, 34(3):199-212.

137.        Nielsen N, Hansen, JPH.: Breast cancer in Greenland-selected epidemiological, clinical and histological features. J Cancer Res Clin Oncol 1980, 98:287-299.

138.        Terry P, Lichtenstein, P, Feychting, M, Ahlbom, A, Wolk, A.: Fatty fish consumption and risk of prostate cancer. Lancet 2001, 357:1764-1766.

139.        Wargovich MJ: Fish oil and colon cancer. Gastroenterology 1992, 103(3):1096-1098.

140.        Caygill CP, Charlett A, Hill MJ: Fat, fish, fish oil and cancer. Br J Cancer 1996, 74(1):159-164.

141.        Lindner MA: A fish oil diet inhibits colon cancer in mice. Nutr Cancer 1991, 15(1):1-11.

142.        Mandal CC, Ghosh-Choudhury T, Yoneda T, Choudhury GG, Ghosh-Choudhury N: Fish oil prevents breast cancer cell metastasis to bone. Biochem Biophys Res Commun, 402(4):602-607.

143.        Moreira AP, Sabarense CM, Dias CM, Lunz W, Natali AJ, Gloria MB, Peluzio MC: Fish oil ingestion reduces the number of aberrant crypt foci and adenoma in 1,2-dimethylhydrazine-induced colon cancer in rats. Braz J Med Biol Res 2009, 42(12):1167-1172.

144.        Chiang KC, Persons KS, Istfan NW, Holick MF, Chen TC: Fish oil enhances the antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 on liver cancer cells. Anticancer Res 2009, 29(9):3591-3596.

145.        Miano L: [Mediterranean diet, micronutrients and prostate carcinoma: a rationale approach to primary prevention of prostate cancer]. Arch Ital Urol Androl 2003, 75(3):166-178.

146.        Yee LD, Young DC, Rosol TJ, Vanbuskirk AM, Clinton SK: Dietary (n-3) polyunsaturated fatty acids inhibit HER-2/neu-induced breast cancer in mice independently of the PPARgamma ligand rosiglitazone. J Nutr 2005, 135(5):983-988.

147.        Simopoulos A: Evolutionary aspects of diet and essential fatty acids. World Rev Nutr Diet 2001, 88:18-27.

148.        Scarmeas N, Stern Y, Mayeux R, Manly JJ, Schupf N, Luchsinger JA: Mediterranean diet and mild cognitive impairment. Arch Neurol 2009, 66(2):216-225.

149.        Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA: Mediterranean diet and risk for Alzheimer’s disease. Ann Neurol 2006, 59(6):912-921.

150.        Appleby PN, Thorogood M, Mann JI, Key TJ: The Oxford Vegetarian Study: an overview. Am J Clin Nutr 1999, 70(3 Suppl):525S-531S.

151.        Key TJ, Appleby PN, Rosell MS: Health effects of vegetarian and vegan diets. Proc Nutr Soc 2006, 65(1):35-41.

152.        Key TJ, Appleby PN, Spencer EA, Travis RC, Roddam AW, Allen NE: Mortality in British vegetarians: results from the European Prospective Investigation into Cancer and Nutrition (EPIC-Oxford). Am J Clin Nutr 2009, 89(5):1613S-1619S.

153.        Key TJ, Appleby PN, Spencer EA, Travis RC, Roddam AW, Allen NE: Cancer incidence in vegetarians: results from the European Prospective Investigation into Cancer and Nutrition (EPIC-Oxford). Am J Clin Nutr 2009, 89(5):1620S-1626S.

Posted in Gerontology | Leave a comment

Interventive Gerontology 1.0.02: First, Try to Make it to the Mean: Diet as a life extending tool, Part 1.

By Mike Darwin

First, Try to Make it to the Mean

For the past two months I’ve been asking people I encounter in public places[1] the question, “How old do you think you’ll live to be?” The answer I get from non-smokers is usually a number somewhere between 75 and 90, regardless of their age. Occasionally, people will remark that they expect to live to be100, or even 120 because of “medical advances,” but mostly people put their prospects at or above the mean lifespan for people living in the US. This shouldn’t be surprising, because the mean life expectancy in the US for men and women combined is currently 77.8 years. Since nobody (except for smokers) wants to be less than average, the lowest number people volunteer is right around the mean lifespan for the population of the US, at present.

Figure 1: In statistics, a median is described as the numerical value separating the higher half of a sample, a population, or a probability distribution from the lower half. The median of a finite list of numbers can be found by arranging all the observations from lowest value to highest value and picking the middle one. If there are an even number of observations, then there is no single middle value; the median is then usually defined to be the mean of the two middle values. At most, half the population has values less than the median, and, at most, half have values greater than the median. If both groups contain less than half the population, then some of the population is exactly equal to the median. For example, if a < b < c, then the median of the list {a, b, c} is b, and, if a < b < c < d, then the median of the list {a, b, c, d} is the mean of b and c; i.e., it is (b + c)/2.

However, life expectancy is not the same as mean, or average lifespan. Rather, life expectancy constitutes the expected number of years, on average, that a particular cohort of individuals in the population will survive if the rate of mortality remains constant (until the maximum lifespan is reached).[2] Life expectancy is thus the median number of years, at birth, that a population born in a particular year is expected to survive. For instance, based on the most recent data, life expectancy at birth in 2008 was 77.8 years.[1] The good news for people in this cohort is that half of them will live longer than 77.8 years, and the bad news is that half of them will not survive to their 77th birthday.

Table 1. U.S. Life Expectancy at Birth,

by Sex, in Selected Years

(in years)

 Source: For data through 2002, the Congressional Research Service (CRS) compilation from National Center for Health Statistics (NCHS), United States Life Tables, 2002, National Vital Statistics Reports, vol. 53, no. 6, Nov. 10, 2004. For 2003, NCHS, Deaths: Final Data for 2003, National Vital Statistics Reports, vol. 54, no. 13, Apr. 19, 2006.[3]

It is also the case that the lifespan of all of the individuals in the nation does not necessarily increase along with the reported statistical mean lifespan for the nation’s population as a whole. As an example, I was born in 1955, and if we look at the cohort survival data from that period, the median life expectancy for males from my cohort is ~ 66 years. Of course, this includes all males in my cohort, including those who died at birth, those who died in various wars, those who died as a result of youthful indiscretion (some fraction of deaths by accident, suicide and homicide), and those who died due to “random” accidents. A more precise estimate of my life expectancy (and yours) can be had by consulting the chart in Figure 2, below.

Figure 2: US life expectancy as a function of age (2008 data set).

Most people seem to assume that they are guaranteed survival to whatever the current mean US lifespan is. Unfortunately, that isn’t the case, and in fact half of them will die before reaching the mean lifespan. So, when I hear immortalists talking about living to be 120 (or longer) as a result of one or more dietary and/or pharmacological interventions or another, my first thought is, “Shouldn’t you be sure you can crawl before you try to fly?” I say this because, as the data show, it’s not all that easy to make it to “average;” half of those who try die! And if you think about it, why they died (failed) is likely to be very important; even if it was from seemingly random things like a drunk driver hitting them head on, or because they had the misfortune to have the genetic predisposition to type I diabetes.

Table 2. Age-adjusted Death Rates for Various Causes of Death

(per 100,000 population)

 

Source: CRS compilation from National Center for Health Statistics (NCHS), Health, United States, 2005 with Chartbook on Trends in the Health of Americans, Table 29.

Of course, most people don’t die from freak accidents; they die from fairly predictable, commonplace and to significant extent avoidable causes, as can be seen in Table 2, above. By far the largest causes of death that prevent people from reaching the statistical mean (or beyond) are cardiovascular disease (CVD) and cancer. To give a better understanding of the percentages, I’ve done a quick and dirty pie chart (Figure 3, below). By far the largest source of theoretically preventable mortality is from cardiovascular disease, and what’s more, interventions that reduce the incidence or severity of CVD also have the potential to reduce the incidence of obesity (in particular, visceral adiposity) and thus the incidence of diabetes. Growing understanding of the biology of atherosclerosis has resulted in dietary interventions, and improved treatment in the form of the statin drugs and coronary revascularization.

Figure 3: Graphic presentation of the leading causes of mortality in the US as a percentage of all deaths.

The first insight into how to prevent, and even reverse atherosclerosis, came in the early 1970s and this insight, and its clinical application have a number of important lessons for today’s ‘do it yourself life extensionists.’

When I arrived in Southern California to work full-time on cryonics in 1974, I stayed for several months with Fred and Linda Chamberlain. I hadn’t been in their home for 24 hours when I was introduced to a book and to a diet that offered the promise of “living to be 100 years old.” The book was titled Live Longer Now and its author, Nathan Pritikin (1915 – 1985), an inventor with no medical background, claimed to have found a diet that would not only prevent atherosclerosis, but also reverse it. I was skeptical at the time, but a decade later I had seen enough firsthand evidence to reconsider Pritkin’s claims. Atherosclerosis most often presents in the form of coronary artery and peripheral artery disease (PAD). While the course is variable in terms of the rate progression, the disease itself is irreversible and by the time it is clinically evident, it has typically been underway for decades.

How not Succeed While Trying: The Pritikin Diet

Figure 4: Nathan Pritikin was the classic outsider to medicine. His background was not even that of an academic, but rather that of a successful inventor who made significant contributions to industrial processes in electronics. He was a consummate scientist: a keen observer with an eye for anomalies in the world around him who generated clever hypotheses, and then hammered them into theory using well designed experiments. He was roundly vilified by the medical and scientific communities of the 1970s thru the late 1980s.  His theory, that reduction of total serum cholesterol to ~120 mg/dl, and in particular LDL cholesterol to ~<80 mg/dl, in combination with a program of weight reduction and modification of the diet to exclude simple carbohydrates, keep fat consumption to ~ 10% of calories and eliminate added salt is now widely accepted in a medicine. [2-15]

I began to see patients with severe coronary artery disease (CAD) and intermittent claudication (PAD) become symptom free and recover excellent levels of exercise tolerance. That prompted me to contact the Pritikin Longevity Center in Santa Barbara, CA in 1982 and to begin closely looking at the data from the clinical study they were doing at the Veterans’ Administration Hospital in Long Beach, CA on patients with well documented CAD and PAD. Their data were unequivocal; the diet was capable of reducing atheromatous plaques in the coronary arteries, as demonstrated by angiography, as well as reversing ST-segment changes associated with myocardial ischemia during exercise (treadmill testing).

Shortly thereafter, I began advocating (as well as personally practicing) the Pritikin diet to Alcor members, and to cryonicists in general, as a way to avoid the catastrophe of Sudden Cardiac Death (SCD), and possibly to live longer, as well.[16, 17] I learned a number of important things from that experience. The first was that very low fat diets were intensely unpleasant for most people, and that even people who were well aware that they were dying from CAD would either not adopt the diet, or became noncompliant after a short while on it.

The first lesson was thus that an intervention that works is of little use (beyond the mechanistic insights it offers) if no one will use it. I also learned that any claims for life span extension, or improved wellbeing and overall health (for any intervention), must be backed up with data demonstrating those claims. In particular, I learned that all-cause mortality was the last and the best word in validating claims of extending lifespan.

The Pritikin diet was, in fact, effective at dramatically reducing morbidity and mortality from CVD and type II diabetes.[2, 13, 14, 18-26] However, because the diet eschewed all fats and restricted the calorie intake in fats to 10-15% of the total calorie intake of the diet, with the emphasis on polyunsaturated fats. As previously noted, it proved almost impossible to persuade Alcor members to adopt the diet,[27] or even to embrace a modified version of it, wherein one day a week was a “diet free day,” during which the individual could eat proscribed foods ad lib, as he chose. Somewhat surprisingly, I am still in contact with all six of the surviving individuals who adopted the Pritikin diet between 1974 and 1985; the maximum period of compliance was 6 years, and none of these individuals is still on the diet. Three of these individuals have been treated for cancer, though I would hasten to add that I do not believe that in any of these cases the Pritikin diet was either causative or contributory.

Near Universal Noncompliance = Failure

The reasons for the noncompliance, and ultimately for abandonment of the Pritikin diet, were not difficult to ascertain. The most pressing and immediate were the near constant cravings for prohibited foods which, contrary to statement from the Pritikin Longevity Center and those present in Pritikin-approved books and publications, did not diminish over time. Hunger, per se, was not a problem, since the bulk amount of food consumed typically increased over baseline, due to the low caloric density of the foods allowed on diet.[28]  Additionally, there were serious problems with mood (irritability and depression), fatigue, reduced ability to concentrate, winter pruritis, binge eating and “constantly feeling cold,” including a much reduced ability to tolerate cool or cold environments when at rest or a low level of activity.[27] There have been no long-term compliance or all-cause mortality studies of the Pritikin diet, however one published study of a nearly identical diet showed very poor compliance at one year.[29]

Since the mid-1980s, a significant amount of evidence has accumulated indicating that the very low serum cholesterol levels required to effect the reversal of atherosclerosis can result in mood disorders leading to increased irritability, and even violence.[30-36] Studies of more modest reductions in dietary fat intake have not shown benefit in reducing morbidity and mortality from CVD or cancer, and there is the suggestion that mortality reductions resulting from decreases in CVD, hypertension, obesity and diabetes may be made up for by increases in the incidence cancer, suicide and homicide.[27, 31, 37] However, the bottom lines is that 30 years later, there is still no evidence indicating that the Pritikin diet reduces all-cause mortality, or that the non-compliance obstacle can be overcome. The absence of effect with moderate (i.e., less extreme) or so called “reduced fat” diets is especially discouraging, because it indicates the likelihood of an “almost all or none” effect with little or benefit obtained from partial compliance.[38-40] This is, in fact, the position that Nathan Pritikin took.[41]

So while the Pritikin diet met Level-1 (Evidence Based Medicine) criteria for reversing atherosclerosis (and in some cases, type II diabetes), it failed to meet the three other claims it made; namely a longer lifespan with the prospect of reaching age 100, greatly reduced incidence of cancer and a healthier happier life as a result of decreased disease burden. Despite its failure as a technique to reduce all-cause mortality,[4] the Pritkin diet was important because it demonstrated for the first time that it was indeed possible not only to prevent or slow atherosclerosis, but to reverse it, as well – and to do so by something as seemingly low technology as dietary intervention. The Pritikin diet was also effective at reversing type II diabetes in many patients, as well as reducing or eliminating the need for antihypertensive medication, especially in patients who were overweight. Despite these formidable advantages, its poor rate of compliance (negligible amongst cryonicists and life extensionists, as well as cardiac patients) and its failure to improve all-cause mortality has made it a practical failure for population-wide application. [5]

Footnotes

[1] One of the best ways to do this is to ask people who are tethered to one spot by work, queuing, or smoking outdoors. Asking people who are waiting in line at a shop or who are workers in shops or restaurants works well as long as your approach is low key, you offer a reasonable explanation for the question and you show genuine interest in their answer.

[2] Life expectancy is a hypothetical measure that applies today’s age-specific death rates to predict the future survival of a cohort. It would technically be more accurate to follow the cohort through time and apply the actual age-specific death rates that the cohort experiences as it moves through its life course, but calculation of actual life expectancy would then require something in excess of 100 years (until the death of the last survivor in the cohort).

[3] Later year estimates are more reliable than those of the early 20th century. The federal civil registration system began in 1900 with the setting up of the Death Registration Area (DRA). States were only admitted as qualification standards were met. Only 10 states and the District of Columbia were in the original DRA of 1900. Statistics prior to 1939-1941 are based on data from the DRA states (which increased in number over time). Alaska and Hawaii are first included in 1959-1961 figures. Also note that data for years 1999-2001 are not reported in this data source.

[4] Absence of evidence is not evidence of absence, but in this case it is strongly suggestive There have been no all cause mortality studies published on the Pritikin diet despite the Pritikin Research Foundation’s heavy emphasis on scientific data to validate claims for the diet. Longitudinal studies of diets require both long term compliance and a study group large enough to draw accurate statistical inferences from.

[5] The Pritikin diet, or its cousin the Ornish diet may still have an important role in the reversal of atherosclerosis in patients who do not wish to undergo coronary artery bypass surgery and who cannot or will not take medication.

References

1.            NVSS: National Vital Statistics Reports :http://www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59_02.pdf. In., vol. 59: Centers for Disease Control and Prevention; 2010.

2.            Barnard RJ, Lattimore L, Holly RG, Cherny S, Pritikin N: Response of non-insulin-dependent diabetic patients to an intensive program of diet and exercise. Diabetes Care 1982, 5(4):370-374.

3.            Weber F, Barnard RJ, Roy D: Effects of a high-complex-carbohydrate, low-fat diet and daily exercise on individuals 70 years of age and older. J Gerontol 1983, 38(2):155-161.

4.            Barnard RJ, Massey MR, Cherny S, O’Brien LT, Pritikin N: Long-term use of a high-complex-carbohydrate, high-fiber, low-fat diet and exercise in the treatment of NIDDM patients. Diabetes Care 1983, 6(3):268-273.

5.            Masley S, Kenney JJ, Novick JS: Optimal diets to prevent heart disease. JAMA 2003, 289(12):1510; author reply 1510-1511.

6.            Masley SC: Dietary therapy for preventing and treating coronary artery disease. Am Fam Physician 1998, 57(6):1299-1306, 1307-1299.

7.            Masley SC, Weaver W, Peri G, Phillips SE: Efficacy of lifestyle changes in modifying practical markers of wellness and aging. Altern Ther Health Med 2008, 14(2):24-29.

8.            Barnard RJ, Jung T, Inkeles SB: Diet and exercise in the treatment of NIDDM. The need for early emphasis. Diabetes Care 1994, 17(12):1469-1472.

9.            Barnard RJ, Hall JA, Chaudhari A, Miller JE, Kirschenbaum MA: Effects of a low-fat, low-cholesterol diet on serum lipids, platelet aggregation and thromboxane formation. Prostaglandins Leukot Med 1987, 26(3):241-252.

10.          Barnard RJ, Ugianskis EJ, Martin DA, Inkeles SB: Role of diet and exercise in the management of hyperinsulinemia and associated atherosclerotic risk factors. Am J Cardiol 1992, 69(5):440-444.

11.          Czernin J, Barnard RJ, Sun KT, Krivokapich J, Nitzsche E, Dorsey D, Phelps ME, Schelbert HR: Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve. Circulation 1995, 92(2):197-204.

12.          Roberts CK, Barnard RJ: Effects of exercise and diet on chronic disease. J Appl Physiol 2005, 98(1):3-30.

13.          Blankenhorn D, Hodis N.: George Lyman Duff Memorial Lecture. Arterial imaging and atherosclerosis reversal. Arteriosclerosis and Thrombosis 1994, 14,:177-192.

14.          Hubbard J, Inkeles, S, Barnard, RJ.: Nathan Pritikin’s Heart. N Engl J Med 1985, 313:52.

15.          Masley S, Kenney, JJ, Novick, JS.: Optimal diets to prevent heart disease. JAMA 2003, 289(12):1510.

16.          Darwin M: Atherosclerosis: answers  bring dilemmas: http://www.alcor.org/cryonics/cryonics8412.txt. Cryonics 1984(53):5-8.

17.          Darwin MH, SB.: Reducing your risk of autopsy: the problem of atherosclerosis. Cryonics 1987, 8(12):32-47.

18.          Barnard R, Pritikin, R,  Rosenthal, R, et al.: Pritikin Approach to Cardiac Rehabilitation; Rehabilitation Medicine. St. Louis: Mosby Company, ; 1988.

19.          Barnard R, Massey, MR, Cheney, S, O’Brien, LT, Pritikin, N.: Long-term use of a high-complex-carbohydrate, high-fiber, low-fat diet and exercise in the treatment of NIDDM patients. Diabetes Care 1983, 6:268-273.

20.          Barnard R, Guzy, J, Rosenberg, LT, et al. : Effects of an intensive exercise and nutrition program on patients with coronary artery disease: a five-year follow-up. J Cardiac Rehab 1983, 3:183-190.

21.          Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA, Sparler S, Armstrong WT, Ports TA, Kirkeeide RL et al: Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998, 280(23):2001-2007.

22.          Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, McLanahan SM, Kirkeeide RL, Brand RJ, Gould KL: Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990, 336(8708):129-133.

23.          Ornish D: Reversing heart disease through diet, exercise, and stress management: an interview with Dean Ornish. Interview by Elaine R Monsen. J Am Diet Assoc 1991, 91(2):162-165.

24.          Ornish D: Can lifestyle changes reverse coronary heart disease? World Rev Nutr Diet 1993, 72:38-48.

25.          Gould KL, Ornish D, Scherwitz L, Brown S, Edens RP, Hess MJ, Mullani N, Bolomey L, Dobbs F, Armstrong WT et al: Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA 1995, 274(11):894-901.

26.          Gould KL, Ornish D, Kirkeeide R, Brown S, Stuart Y, Buchi M, Billings J, Armstrong W, Ports T, Scherwitz L: Improved stenosis geometry by quantitative coronary arteriography after vigorous risk factor modification. Am J Cardiol 1992, 69(9):845-853.

27.          Gittleman A: Beyond Pritikin: A Total Nutrition Program For Rapid Weight Loss, Longevity, & Good Health: Bantam; 1988.

28.          Freedman M, King, J, Kennedy, G.: Popular Diets: A Scientific Review : http://www.nature.com/oby/journal/v9/n3s/pdf/oby2001116a.pdf. Obesity Research 2001, 9(Suppl 1):1-40s.

29.          Thuesen L, Henriksen, LB, Engby, B.: One-year experience with a low-fat, low-cholesterol diet in patients with coronary heart disease. Am J Clin Nutr 1986, 44::212-219.

30.          Golomb BA, Stattin H, Mednick S: Low cholesterol and violent crime. J Psychiatr Res 2000, 34(4-5):301-309.

31.          Kaplan JR, Muldoon MF, Manuck SB, Mann JJ: Assessing the observed relationship between low cholesterol and violence-related mortality. Implications for suicide risk. Ann N Y Acad Sci 1997, 836:57-80.

32.          Wallner B, Machatschke IH: The evolution of violence in men: the function of central cholesterol and serotonin. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33(3):391-397.

33.          Golomb BA, Kane T, Dimsdale JE: Severe irritability associated with statin cholesterol-lowering drugs. QJM 2004, 97(4):229-235.

34.          Rose N, Koperski S, Golomb BA: Mood food: chocolate and depressive symptoms in a cross-sectional analysis. Arch Intern Med, 170(8):699-703.

35.          Ainiyet J, Rybakowski J: [Low concentration level of total serum cholesterol as a risk factor for suicidal and aggressive behavior]. Psychiatr Pol 1996, 30(3):499-509.

36.          Fawcett J, Busch KA, Jacobs D, Kravitz HM, Fogg L: Suicide: a four-pathway clinical-biochemical model. Ann N Y Acad Sci 1997, 836:288-301.

37.          Wells A, Read, NW, Laugharne, JDE, Ahluwalia, NS. : Alterations in mood after changing to a low-fat diet. British Journal of Nutrition 1998, 79:23-30.

38.          Krauss R: Low-fat dietary pattern and risk of cardiovascular disease in the Women’s Health Initiative Randomized Controlled Dietary Modification Trial. Curr Atheroscler Rep 2007, 9(6):431-433.

39.          Prentice RL, Caan B, Chlebowski RT, Patterson R, Kuller LH, Ockene JK, Margolis KL, Limacher MC, Manson JE, Parker LM et al: Low-fat dietary pattern and risk of invasive breast cancer: the Women’s Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006, 295(6):629-642.

40.          Tinker LF, Bonds DE, Margolis KL, Manson JE, Howard BV, Larson J, Perri MG, Beresford SA, Robinson JG, Rodriguez B et al: Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women’s Health Initiative randomized controlled dietary modification trial. Arch Intern Med 2008, 168(14):1500-1511.

41.          Leonard J, Hofer, JL, Pritikin, N.: Live Longer Now: Grosset & Dunlap; 1974.

Posted in Gerontology, Medicine, Uncategorized | 1 Comment

Fortune and Men’s Eyes

When in disgrace with fortune and men’s eyes
I all alone beweep my outcast state,
And trouble deaf heaven with my bootless cries,
And look upon myself, and curse my fate,
Wishing me like to one more rich in hope,
Featured like him, like him with friends possessed,
Desiring this man’s art, and that man’s scope,
With what I most enjoy contented least;
Yet in these thoughts my self almost despising,
Haply I think on thee, and then my state,
Like to the lark at break of day arising
From sullen earth, sings hymns at heaven’s gate;
For thy sweet love remembered such wealth brings
That then I scorn to change my state with kings.

- William Shakespeare, Sonnet 29

By Mike Darwin

People support religion because they find it rewarding to do so for many excellent reasons. It provides a community of people with similar beliefs that validate and strengthen each other. It is specifically designed as a crisis resource – somewhere to turn when people are feeling lost, afraid, uncertain or alone. It has powerful pragmatic advantages because it provides people with in-person social networking that is frequently of use in business, child care and as a resource for practical advice and help with many of life’s troubles. Very importantly, religion serves as a source of the dissolution of or absolution from existential guilt. Just by the act of living we compromise or deprive others both of quality life, and of life itself.

It is axiomatic that by forgoing the luxuries we all enjoy we could save others from starvation and disease – and yet we do not. In our daily lives we also injure others, both knowingly and unknowingly, and these things are, to empathetic people, a source of guilt and discomfort – if not outright pain.

Religion offers both forgiveness and concrete ways that we can address these sources of moral ennui in our lives. It is also often a source of very real material and emotional support for those who find themselves down on their luck, sick, old or dying. A good religion takes care of its own and ensures that no member of the flock is turned out on the street to die a beggar. Finally, and perhaps most importantly, religion provides a narrative for peoples’ lives – a story that allows them to make some sense out of what appears to be an otherwise senseless existence,. It doesn’t matter if the narrative is scientifically valid, or if it is especially credible as long as it provides both hope and meaning. Closely related are the promises of an afterlife, not just for the individual, but for his family and community, as well.

Those are excellent reasons to be involved in a religion and to try to believe, even if you don’t. Indeed, all of the “old” religions spend a great deal of time on the subject of “struggling with belief” and an essential ingredient of a saint in Catholicism (Roman and Orthodox) is that the saint have struggled powerfully with doubt – in fact that they be wracked with it. Since sainthood is generally a singularly unrewarding thing in this life, it seems only reasonable that doubt about the wisdom of such a course of action be a material part of the experience. I would be an incredible liar if I said that I do not mock certain specifics of religions, or that I do not, as Curtis Henderson often did, remark, “How can they seriously believe that crap!” But that is not the same as holding religion in contempt, or considering it insane and useless. Religion exists because it meets many deep and abiding needs, including man’s search for meaning – his search for a narrative to make sense of it all. That desire is frequently mocked by people in cryonics and immortalism, and that is both an injustice and a mistake.

Humans are story creatures. We can only understand our world on a daily working basis through narrative. A few of our species can use mathematics to understand the world, but even now there are no maths do not that not require some narrative to relate mathematical insights to the world we inhabit. Most of technology is a result of narrative processes, and the scientific method itself is the essence of a story, in that it has a beginning, a middle and an end: observation, experimentation, hypothesis, experimentation and theory. The scientific method is the (so far) ultimate refinement of the tool of narrative to give us a coherent, and in this case valid understanding of our world. We are also time-creatures, and the essence of a story is what happens over time. We, and the stories we tell, real or imagined, valid or invalid, are thus bound by and included in the Chronosphere.

 The thing that killed far more people in the concentration camps of Hitler, Stalin, Mao and Pol Pot than starvation was hopelessness. Strip away hope and you will soon end life. Emily Dickinson may have been right when she said, “Hope is the thing with feathers that perches in the soul…” However, she was certainly wrong when she went on to say, “Yet, never, in extremity, It asked a crumb of me.” Hope requires lots of feeding and is does best when it is raised up on a diet of rational, responsible caring. Hope must be credible and its manifestations must be real and apparent. People seek meaning and succor in religion because they can both see and personally experience its benefits – not just in a promised afterlife, but here and now. One reason for the failure of cryonics organizations is that they are as cold and unfeeling as the stainless steel dewars and liquid nitrogen they employ in the only visible manifestation of their temporal work. Yes, there is some comfort in that, but you don’t even get to touch it until you’re “dead.”

While you are alive what you get from them is bills and yet more requests for money. You get a newsletter which is about as involved and caring for the narrative of your life, and your experience of it, as is an issue of Scientific American or Wired. In fact, it might be argued that those publications are more concerned with your interest and enjoyment of what is to come, because their articles involve you in the putative futures they discuss, if in no other way than asking questions and giving answers with the words “we” and “you” in them. “Will we discover that there are indeed countless universes…” or “So, someday you may well pull up to the pump and instead of filling your car with petrol, you’ll recharge your recharge your tank, which contains a matrix of complex metal hydride, with hydrogen…”

To take and take and take and not to care, not to really care (or to be able to show it) can in no way compete with what is available at any Kiwanis Club, Moose Lodge, Temple or Church. To leave people without a narrative, without a community, without a sense of overarching purpose and without even the hint of charity, should they be in need, is not a recipe for success.

Cryonics, and indefinitely extended life in youthful good health, which it implies, is a powerful and profoundly good idea which will revolutionize the world and prepare us to spread to other worlds. That is a potent message that is both inspired and inspiring and for which men will lay down their nets (and webs) and go forth and work to make it a reality. But they cannot do that absent the narrative, and they cannot do that absent the community, and they most certainly cannot do that absent both leadership and support. Cryonics will continue to grow slowly, often in ways detrimental to its survival and it will remain weak and divided until, at some point in the interesting times ahead, it comes to the attention of important people. At that point its narrative will be over, and the ending will have been written not by us, but by our enemies – the enemies of life itself.

Posted in Cryonics History, Cryonics Philosophy, Culture & Propaganda | 4 Comments

Interventive Gerontology 101.01: The Basics

 

Calorie Restriction: First You Starve and Then You Die (Horribly)

Figure 1: Supercentenarians in “extreme old age”:  Jeane Calmette, 121; Ingeborg Mestad, 110; Walter Breuning, 114; Marie-Louise Meilleur, 117.

There’s a proven technique in animals for reaching the maximum lifespan; the longest time that animals of a given species have the inherent capacity to survive. It’s called calorie restriction, and there is a large body of animal data in an impressive range of species that says it works. There is even an ongoing project being conducted by the National Institutes of Aging (NIA) to evaluate calorie restriction in primates and it seems to be working in them, too. The calorie restricted Rhesus macaque monkeys have lower death rates, lower rates of age-associated degenerative diseases, and their overall health and activity level are dramatically better than is the case for the control animals, who are fed a diet that simulates the ad lib calorie intake by humans in the Developed World.

There’s just one catch, and that is that calorie restriction, to the extent necessary to get the individual to the maximum end of the lifespan envelope is, for most humans, a miserable experience. It is also one fraught with the potential for malnutrition and the development of eating disorders, such as anorexia nervosa and bulimia. But there’s another problem with calorie restriction in humans, and that’s that the end results are that you end up a blind, debilitated old crone or codger, and then you die.

Having said that, I don’t want to minimize or dismiss the probable very real advantages of calorie restriction in humans and they are that there is likely to be, on average, a 15-25 year extension of the healthy and reasonably productive lifespan, with a large decrease in most of quality of life eroding (and costly) degenerative diseases, such as diabetes, cardiovascular disease, osteoarthritis, dementia and very likely, tooth decay and gum disease. That’s impressive, even if it isn’t very practical for most people without some kind of pharmacological assistance.

There is also ongoing research to discover drugs that mimic the effects of calorie restriction on gene expression so that the benefits of the technique can be had without the attendant suffering and the very real risks of adverse effects on psychology and nutrition.[1] This is a promising area of research, and it will be covered here in considerable detail on an ongoing basis. However, this is not the time to start any discussion of  specific ‘evidence based’ technologies for extending healthy lifespan. Indeed, before we go any further, it is necessary to become familiar with the concept of evidence based medicine (EBM) (Figure 2).

Evidence Based Medicine

 

Figure 2:  Detailed Diagrammatic representation of the levels of evidence used in Evidence Based Medicine.

Evidence-based medicine (EBM), also called evidence-based practice (EBP) aims to apply the best available evidence gained from the scientific method to clinical decision making. It seeks to assess the strength of evidence of the risks and benefits of treatments, including the lack of treatment, and diagnostic tests.Evidence quality can range from meta-analyses and systematic reviews of double-blind, placebo-controlled clinical trials at the top of the pyramid (above), to conventional wisdom at the bottom.

The discrete types or levels of evidence I will be using in all my discussions here on Chronosphere are those of the Centre for Evidence Based Medicine (CEBM),  as set out in their “’Levels of Evidence’ Document” which is reproduced, below.

1. A summary of how evidence can be graded.

In simple terms, one way of looking at levels of evidence is as follows (the higher the level, the better the quality; the lower, the greater the bias):

or…

  • Category I:  Evidence from at least one properly randomized controlled trial.
  • Category II-1: Evidence from well-designed controlled trials without randomization.
  • Category II-2: Evidence from well-designed cohort or case-control analytic studies, preferably from more than one center or research group.
  • Category II-3: Evidence from multiple times series with or without intervention or dramatic results in uncontrolled experiments such as the results of the introduction of penicillin treatment in the 1940s.
  • Category III: Opinions of respected authorities, based on clinical experience, descriptive studies and case reports, or reports of expert committees.

[Source: Harris, R.P. et al. (2001). Current methods of the U.S. Preventive Services Task Force: a review of the process. American Journal of Preventive Medicine. April 20 (3 Supplement): 21-35.]

Not surprisingly, the place to start in looking for any reliable method(s) of life extension is at the top of the evidence pyramid, which consists of Systematic Reviews (including well designed meta-analyses) and Randomized Double Blind Clinical Studies.

Figure 3: The EBM pyramid made simple.

The majority of “amateur interventive gerontologists,” or active “life extensionists” who are pursuing lifespan extending therapies on themselves are usually both surprised and dismayed when looking at this pyramid (Figure 3). The first reason for this is that either all, or almost all, of the interventions they are using are at the very bottom of the pyramid. The second reason for the shock and dismay (and often disbelief) is that animal and in in vitro research rank below the ideas, editorializing and opinions of medical professionals, instead of at the top of the pyramid, where most activist life extensionists typically feel they should belong.

However, the fact is that very little animal, or in vitro research has any direct clinical applicability to humans.[2-4] This is not because government regulations or “greedy” pharmaceutical companies don’t want people to benefit from disease-curing or life extending drugs, but rather, because the vast majority of that research is either bad (junk) science or it fails to translate to humans.[4-10] Even when animal studies are well designed and carried out in relevant animal models of disease and show strongly positive results, mostly these findings fail to translate to humans. There are many reasons for this, but chief amongst them is that animals, despite their high ‘percentage’ of genetic overlap with humans, are really biochemically sufficiently different that the findings aren’t applicable to humans. The public are bombarded with numbers, such as chimpanzees are 96% to 98% genetically homologous with humans; cats: 90%, dogs: 82%, cows: 80%, rats: 69% and mice: 67% (http://www.ncbi.nlm.nih.gov/homologene).  These numbers get even more impressive when it is noted that 75% of mouse genes have equivalents in humans and 90% of the mouse genome can be matched to a comparable region on the human genome. In fact, recent research indicates that ~ 99% of mouse genes turn out to have analogs in humans.

Figure 4: If we were mice, most cancers would be treatable or cured, there would be effective drugs for stroke and cerebral ischemia, and a wide range of other conditions would have effective therapies. However, we are not mice.

So what’s the problem with the applicability of animal research to humans? Well, consider that at in 3 out of ten patients the drug prescribed for them fails to work. It’s not that the patient is non-compliant or just doesn’t get better; it is that the drug failed to have the anticipated therapeutic effect. Thus, in those patients, the drug was a waste of money and time; and to the extent that it may have adverse effects, a real danger. In fact, there are 2.2 million serious cases of adverse drug reactions (ADRs) and over 100,000 deaths each year in the US. That makes (ADRs) one of the leading causes of hospitalization and death in the US! Most people take ADRs and lack of therapeutic effect in the drugs they are prescribed (or purchase over the counter (OTC)) for granted. “Oh, that doesn’t work for me,” or “I can’t take that because…” are commonplace remarks. And they apply to people who use only “natural” or herbal remedies as much or more as they do those who use “synthetic” drugs.

The reason for these phenomena is very instructive about why animal research turns out to have so little applicability to humans. The cause of the huge variation in responsiveness to drugs in humans is genetic variation between individuals; even identical twins are not genetically identical, due to mutations and to variations in gene activation (epigenetic factors).[11] There are two types of genetic variations known to impact drug metabolism; copy number variation, which results from deletions, inversions, insertions and duplications in genes, and nucleotide variations, or single nucleotide polymorphisms (SNPs). It is estimated that approximately 0.4% of the genomes of unrelated people typically differ with respect to gene copy number. The nucleotide diversity (SNPs) between humans is about 0.1%, which is 1 difference per 1,000 DNA base pairs! Combine these two numbers and human genetic variation is estimated to be at least 0.5% or, if you prefer, 99.5% similarity between individuals.[11-13]

That seemingly trivial amount of genetic variation is responsible for the observed and well documented large disparity in response to therapeutic drugs observed within the human species. Even the SNPs (pronounced “snips”) have a profound effect on the response (or lack thereof) to therapeutic drugs and they are the sources of a major research effort to develop a catalog of SNPs that can be used as a diagnostic tool to predict and individual person’s drug response. This rapidly developing area of research is called pharmacogenomics and it has already seen clinical application in cancer chemotherapy, anticoagulant dosing, the treatment of Hepatitis C and psoriasis, and in seizure disorders.[14-20]

New Drug Development: May I Suggest Roulette, Instead?

A few more words need to be said about the drug development research and success. Leaving animal data aside, most human clinical trials to evaluate refinements of existing (and proven) drugs or therapies either fail, or result in active harm.[2, 21-23] The chances of a novel molecule making it from in vitro or animal testing to clinical use in humans are ~ 1,000 to 1. You’d be much, much better off playing straight-up roulette, where the odds against you are only 37 to 1. Even in studies or clinical trials where there are ample existing theory and prior in vitro, animal research and clinical trials data that were positive and point compellingly to a favorable outcome, trials often fail.

A good example of this with direct relevance to life extensionists is the saga of vitamin E in the treatment and prevention of atherosclerosis, and in particular, coronary artery disease.There are many animal experiments showing that vitamin E reduces or inhibits the development of atherosclerosis. Epidemiological studies in humans provided robust support to these data, since consumption of vitamin E in the diet was inversely associated with mortality from cardiovascular disease.[24, 25] And to the theoreticians and mechanists, there was the perhaps even more compelling fact that the free radical biochemistry implicated as being a primary factor underlying atherogenesis (oxidized low density lipoprotein (LDL)) is favorably impacted by the addition of vitamin E and similar chain breaking antioxidants to the diet in supraphysiological amounts.[26] The free radical theory of aging also supports the idea that vitamin E and other antioxidant molecules might reduce the incidence of degenerative disease, and perhaps retard aging. Further, in accordance with both theory and the animal data, administration of vitamin E to human volunteers reduced the level of lipid peroxidation, and in particular reduced the level of oxidized LDL.[27]

Figure 5:*NHS indicates Nurses’ Health Study; HPS, Health Professionals’ Follow-up Study; EPESE, Established Populations for Epidemiologic Studies of the Elderly; IWHS, Iowa Women’s Health Study; MI, myocardial infarction; and ellipses, none.

Several prospective studies in which vitamin E was given as a supplement, including the US Nurses’ Health Study[28] and the US Health Professionals’ Follow-up Study, found a 34% and 39% reduction (respectively), in the incidence of myocardial infarction, [29] More impressively still, the  Iowa Women’s Health Study found a 47% reduction in cardiac mortality.[30] These were not small studies published in obscure journals. They were very large trials (Figure 5) and they were published in the New England Journal of Medicine. So what’s the problem? The problem was that other researchers could not duplicate the results and so subsequent, carefully designed trials were conducted.

The largest and best designed of these was the a randomized, placebo-controlled Medical Research Council/British Heart Foundation (MRC/BHF) Heart Protection Study in which antioxidant vitamin supplementation was examined in 20,536 individuals with coronary disease, other occlusive arterial disease, or diabetes mellitus. The study participants were randomized to receive vitamin E (600 mg), vitamin C (250 mg), and beta carotene (20 mg) daily or matching placebo. Intention-to-treat comparisons of outcome were conducted among all participants. An advantage to this study was that critics of earlier failed trials pointed out that vitamin E can act as a pro-oxidant in the absence of vitamin C and that it has in vitro pro-oxidant activity in cell membrane lipids under some conditions. In vivo, vitamin C is the molecule which disposes of the water soluble radical species that can be generated by vitamin E and beta carotene was added to scavenge lipid soluble radicals.

The MRC/BHF study found no significant differences between the vitamin and placebo groups in all-cause mortality, or in deaths caused by vascular or nonvascular conditions. Nor were there any significant differences between groups in the incidence of nonfatal myocardial infarction or sudden cardiac death, nonfatal or fatal stroke, or coronary or non-coronary re-vascularization. In fact, the study found that the use of antioxidant vitamins did not produce any significant reductions in 5-year mortality from, or incidence of, any type of vascular disease, cancer, or other major outcome, compared with placebo.[31]

Other studies also showed no benefit [32-34] and there was even some suggestion of harm in the form of an apparent increase in mortality and morbidity from gastrointestinal and intracranial bleeding. In 2009, a metanalysis of vitamin E supplementation trials by Dotan, et al., using Markov model analysis showed that the vitamin E supplemented “virtual cohort” had 0.30 decrease in their quality-adjusted life year (QALY) (95%CI 0.21 to 0.39) compared to the non-treated “virtual cohort.”[35] QALY is a statistical measurement tool used to evaluate not just death or discrete injurious events, such as heart attack or hemorrhagic stroke, but rather measure these events, along with all deaths or debilities as a single entity, and report them in terms of how much loss or gain of functional life occurs in a given group. This work supports an earlier metanalysis showing increased all-cause mortality associated with vitamin E doses ~500 mg/day or more. When a metanalysis was done to look specifically for the effects of vitamin E on stroke it was found that vitamin E increased the risk for hemorrhagic stroke by 22% and reduced the risk of ischemic stroke by 10%.[1]

The metanalysis indicating that vitamin E supplementation (≥500 mg q.d.) is associated with an increase in morbidity and mortality is consistent with the known effect of vitamin E in such doses on bleeding time. Supraphysiologic vitamin E antagonizes vitamin K and causes platelet dysfunction resulting in an increased prothrombin time. It is almost axiomatic in medicine that any increase in bleeding time (anticoagulation) is associated with an increased incidence of clinically significant gastrointestinal (GI) and intracranial bleeding. For vitamin E to show benefit, it would be necessary for any increase in adverse effects to be offset by the benefits it conferred. For vitamin E, this was not the case, whereas for aspirin, which also increases bleeding time and causes an increased incidence of GI and intracranial bleeding, shows such strong benefit in the reduction of myocardial infarction that it is worth the associated risk in the appropriate patient population (i.e., those 50 or over and those with known cardiovascular disease).

This kind of “reversal of fortune” happens over and over again in medicine with respect to drugs as as to other treatment interventions and it is one of the well justified reasons why the astute clinician is very skeptical about putative therapies to treat disease that have not been scientifically vetted – preferably repeatedly, internationally and in well designed and executed trials. It is thus an unfortunate reality that no matter how compelling a therapy seems theoretically or in the laboratory, it still must be proven clinically. And it is even truer that the overwhelming majority of putative therapeutic interventions either fail to work, or injure or kill the patient. There is absolutely no reason to think that this will not be the case with putative life extension drugs.

It is also usually the case that taking multiple drugs, or polypharmacy as it is formally known, negatively shifts the risk to benefit ratio (especially in the ill the debilitated or the elderly). This is so because the biochemistry of living systems is not only enormously complex; it is also interdependent and self regulating. The vast majority of drugs, or supraphysiological doses of nutrients, will perturb multiple biochemical pathways and the more molecules administered, the more likely it becomes resulting adverse interactions will occur. It is, as the Taoist maxim cautions, virtually impossible “to do just one thing” when dealing with a complex and dynamic system. Alter one part of the system in a desirable way and there will likely be consequences in other parts of it – and the odds are high that they will not be favorable.[2]

Thus, in making decisions about which putative life extension therapies to use, the most rational course is to start with those where there is Level-1 evidence of benefit. That may not even seem possible, since there are no known lifespan extending drugs or treatments in humans, let alone ones that have undergone extensive, well designed and repeated clinical trials. Or are there? The answer to that question will be the subject of the next article in this series.

Footnotes


[1] While the 10% reduction in the risk of ischemic stroke may seem promising this is really constitutes no advantage since hemorrhagic strokes have a far higher mortality and morbidity rate than is the case for ischemic stroke.

[2] Like mutations, most arbitrary alterations to the biochemistry or gene expression of a complex living system are not likely to result in benefit.

 References

1.            Ingram D, Zhu, M, Mamczarz, J, Zou, S, Lane, MA, Roth, GS, deCabo, R.: Calorie restriction mimetics: an emerging research field. Aging Cell 2006, 5(2):97-108.

2.            Ikonomidou C, Turski L: Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol 2002, 1(6):383-386.

3.            Ozdemir FN, Akcay A, Elsurer R, Sezer S, Arat Z, Haberal M: Interdialytic weight gain is less with the Mediterranean type of diet in hemodialysis patients. J Ren Nutr 2005, 15(4):371-376.

4.            Whiteside GT, Adedoyin A, Leventhal L: Predictive validity of animal pain models? A comparison of the pharmacokinetic-pharmacodynamic relationship for pain drugs in rats and humans. Neuropharmacology 2008, 54(5):767-775.

5.            Harber LC, Armstrong RB, Ichikawa H: Current status of predictive animal models for drug photoallergy and their correlation with drug photoallergy in humans. J Natl Cancer Inst 1982, 69(1):237-244.

6.            Olson H, Betton G, Robinson D, Thomas K, Monro A, Kolaja G, Lilly P, Sanders J, Sipes G, Bracken W et al: Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol 2000, 32(1):56-67.

7.            Pound P, Ebrahim, S, Sandercock, P, Bracken, MB, et al.: Where is the evidence that animal research benefits humans?: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC351856/pdf/bmj32800514.pdf. BMJ 2004, 328:514-517.

8.            Dixit R, Boelsterli UA: Healthy animals and animal models of human disease(s) in safety assessment of human pharmaceuticals, including therapeutic antibodies. Drug Discov Today 2007, 12(7-8):336-342.

9.            Caldwell J: Problems and opportunities in toxicity testing arising from species differences in xenobiotic metabolism. Toxicol Lett 1992, 64-65 Spec No:651-659.

10.          Wilbourn J, Haroun L, Heseltine E, Kaldor J, Partensky C, Vainio H: Response of experimental animals to human carcinogens: an analysis based upon the IARC Monographs programme. Carcinogenesis 1986, 7(11):1853-1863.

11.          Bruder CE, Piotrowski A, Gijsbers AA, Andersson R, Erickson S, Diaz de Stahl T, Menzel U, Sandgren J, von Tell D, Poplawski A et al: Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles. Am J Hum Genet 2008, 82(3):763-771.

12.          Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, Sherry S, Mullikin JC, Mortimore BJ, Willey DL et al: A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001, 409(6822):928-933.

13.          Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N et al: Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 1999, 22(3):231-238.

14.          Beaulieu M, de Denus S, Lachaine J: Systematic review of pharmacoeconomic studies of pharmacogenomic tests. Pharmacogenomics, 11(11):1573-1590.

15.          Beery TA, Smith CR: Genetics/genomics advances to influence care for patients with chronic disease. Rehabil Nurs, 36(2):54-59, 88.

16.          Cacabelos R, Hashimoto R, Takeda M: Pharmacogenomics of antipsychotics efficacy for schizophrenia. Psychiatry Clin Neurosci, 65(1):3-19.

17.          Johnson JA, Liggett SB: Cardiovascular pharmacogenomics of adrenergic receptor signaling: clinical implications and future directions. Clin Pharmacol Ther, 89(3):366-378.

18.          Schwab M, Schaeffeler E, Zanger UM, Brauch H, Kroemer HK: [Pharmacogenomics: hype or hope?]. Dtsch Med Wochenschr, 136(10):461-467.

19.          Kamal SM: Hepatitis C virus genotype 4 therapy: progress and challenges. Liver Int, 31 Suppl 1:45-52.

20.          Yoshida S, Sugawara T, Nishio T, Kaneko S: [Personalized medicine for epilepsy based on the pharmacogenomic testing]. Brain Nerve, 63(4):295-299.

21.          Wiendl H, Neuhaus O, Kappos L, Hohlfeld R: [Multiple sclerosis. Current review of failed and discontinued clinical trials of drug treatment]. Nervenarzt 2000, 71(8):597-610.

22.          Corman LC, Davidson RA: Why clinical trials fail: the hidden assumptions of clinical trials. South Med J 1992, 85(2):117-118.

23.          Krum H, Tonkin A: Why do phase III trials of promising heart failure drugs often fail? The contribution of “regression to the truth”. J Card Fail 2003, 9(5):364-367.

24.          Rimm E, Stampler, MJ, Ascherio, A, Giovannuci, E, Willett, GA, Colditz, WC.: Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993, 328::1450-1455.

25.          Stampfer M, Hennekens, CH, Manson, JE, Colditz, GA, Rosner, B, Willett, WC.: Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993, 328:1444-1449.

26.          Stampfer M, Rimm, EB: Epidemiologic evidence for vitamin E in prevention of cardiovascular disease. Am J Clin Nutr 1995, 62:1365S-1369S.

27.          Reaven P, Witztum JL.: Comparison of supplementation of RRR-alpha-tocopherol and racemic alpha- tocopherol in humans. Effects on lipid levels and lipoprotein susceptibility to oxidation. Arteriosclerosis, Thrombosis, and Vascular Biology 1993, 13:601-608.

28.          Stampfer M, Hennekens, CH, Manson, JE, Colditz, GA, Rosner, B, Willett, WC.: A prospective study of vitamin E consumption and risk of coronary disease in women. N Engl J Med 1993, 328:1444-1449.

29.          Rimm E, Stampfer, MJ, Ascherio, A, Giovannucci, E, Colditz, GA, Willett, WC.: Vitamin E supplementation and the risk of coronary heart disease among men. N Engl J Med 1993, 328:1450-1456.

30.          Kushi L, Folsom, AR, Prineas, RJ, Mink, PJ,Wu,Y, Bostick, RM.: Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 1996, 334:1156-1162.

31.          Aizawa K, Shoemaker JK, Overend TJ, Petrella RJ: Metabolic syndrome, endothelial function and lifestyle modification. Diab Vasc Dis Res 2009, 6(3):181-189.

32.          Yusuf S, Dagenais, G, Pogue, J, Bosch, J, Sleight, P.: Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators:  http://content.nejm.org/cgi/content/full/342/3/154. N Engl J Med 2000;, 342(3):154-160.

33.          Lonn E, Bosch, J, Yusuf, S, Sheridan, P, Pogue, J, Arnold, JM, et al.: HOPE and HOPE-TOO Trial Investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005;, 293(11):1338 -1347.

34.          Vivekananthan D, Penn, MS, Sapp, SK, Hsu, A, Topol, EJ.: Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomized trials. Lancet 2003, 1:2017 -2023.

35.          Dotan YP, I. Lichtenberg, D.  Leshno, M.: Decision analysis Supports the paradigm that Indiscriminate supplementation of vitamin E does more harm than good. Arterioscler Thromb Vasc Biol 2009, 29:1304-1309.

 



Posted in Gerontology | 17 Comments

The Kurzwild Man in the Night

Ray Kurzweil with a portrait of his father.

It’s as if you took a lot of very good food and some dog excrement and blended it all up so that you can’t possibly figure out what’s good or bad. It’s an intimate mixture of rubbish and good ideas, and it’s very hard to disentangle the two, because these are smart people; they’re not stupid.”

– Douglas Hofstadter, author of Gödel, Escher, Bach, on the books of Ray Kurzweil and Hans Moravec. [See Ross, Greg. "An interview with Douglas R. Hofstadter." American Scientist. Retrieved 2011-08-10.]

It is not very often that I see something that simultaneously evokes sympathy, anger and pity. I am a regular viewer of ABC’s “Nightline program which airs beginning at 2330 in most of the US. It’s part of my ‘wind-down ritual’ at the end of the day. Often, I’m reading, or otherwise engaged while the bits and bytes comprising the program make their way from geosynchronous orbit and chatter out of the television. The introduction to the 09 August program caught my attention, because it was to feature Ray Kurzweil, talking about practical immortality. Of course, I know who Kurzweil is – both of them. There is the maverick Edisonian inventor who brought us the Kurzweil Reader (and thus the CCD flatbed scanner and the text-to-speech synthesizer) and the Kurzweil who transformed digital musical instrumentation with his Kurzweil K250 music synthesizer. And then, well then there is the Ray Kurzweil who brought us the idea of the Singularity, and three books that expound scientifically bankrupt ideas for ‘do it yourself’ interventive gerontology: The 10% Solution for a Healthy Life Fantastic Voyage: Live Long Enough to Live Forever, TRANSCEND: Nine Steps to Living Well Forever.

And last, but by no means least, there is the Ray Kurzweil who made one of the creepiest movies I’ve ever seen, “The Singularity is Near,” which I viewed as a rough cut in a private screening in Europe. That film was the near perfect combination of suggested transgendered autoerotic pedophilia with narcissism of cosmic proportions. I watched it, immobilized as one is when witnessing a public beheading, or the torture of small animals in an Egyptian souk. I was immobilized in a way that only disbelief and shock immobilize you. An extended trailer of his latest documentary, Transcendent Man is available here: http://transcendentman.com/

The “Nightline” segment on Kurzweil opened as follows:

“Ray Kurzweil, a prominent inventor and “futurist” who has long predicted that mind and machine will one day merge, has been making arrangements to talk to his dead father through the help of a computer.

“I will be able to talk to this re-creation,” he explained. “Ultimately, it will be so realistic it will be like talking to my father.”

Kurzweil’s father, an orchestra conductor, has been gone for more than 40 years.
However, the 63-year-old inventor has been gathering boxes of letters, documents and photos in his Newton, Mass., home with the hopes of one day being able to create an avatar, or a virtual computer replica, of his late father. The avatar will be programmed to know everything about Kurzweil’s father’s past, and will think like his father used to, if all goes according to plan.

“You can certainly argue that, philosophically, that is not your father,” Kurzweil said. “That is a replica, but I can actually make a strong case that it would be more like my father than my father would be, were he to live.”
Said to look and sound like Woody Allen’s nerdier younger brother, Kurzweil has been working on predicting the future for decades. At age 17, he was invited to appear on the CBS show “I’ve Got a Secret” to demonstrate how a computer program he invented could compose music.

Kurzweil went on to invent optical scanners, machines that read for the blind and synthesizers. Still inventing today, Kurzweil has developed a reputation for himself from just making predictions, mostly about how fast our technology is advancing.”
The program continued to document Kurzweil’s plan to recreate his father, and he argues that this can be done by using documents, photographs and his own memory of the man. At one point, he even asserts that such an emulation would be “more like my father than my father, had he lived.”

Sympathy? Yes, I felt a great deal of sympathy because I too have lost those I have loved to death, and also suffered, and suffer still, because I lack the power to bring them back to life.

Anger? Yes, a fair bit of anger because what Kurzweil is proposing insults the intelligence of anyone who has even the sketchiest conception of what it is to be human. The idea that a person can be inferred from boxes of paper documents and photographs with technology, extant or foreseeable, let alone in Kurzweil’s possession now, is ludicrous. That Kurzweil’s insight into the nature of personhood, including his own, is so shallow and uni-dimensional goes a long way towards explaining the cluelessness with which he is pursuing his social engineering campaign to make radical life extension, cryonics and uploading socially acceptable.

The “Nightline” program was surprisingly respectful and matter of fact. Kurzwel has superb public relations people and the “Nightline” editors were amply stocked with photos, film clips and in short, a very impressive visual montage to accompany Kurzweil’s modest proposal for resurrection of the dead from letters, news clippings, old photos and presumably rent receipts and cancelled checks documenting visits to the dentist or the haberdasher.

But as even most of the most unreflective and superficial dullards understand, if only emotionally, a person is not and cannot be reconstructed from the empty wrappers of a life long ended. A few bars of melody, a scent, a fragment of a recorded voice, the taste of something long forgotten, all of these can, and do from time to time evoke in reflective and self aware people, streams of memories, and with those memories countless connections, relationships, thoughts sounds, sensations and yes, and very importantly, feelings. One of the things I found so appalling and so narcissistically selfish about the Kurzweil interview is that he is not really interested in having his father live again, rather he is only interested in having his personal experience of his father available for his self-gratification again. It doesn’t matter what his father thinks or feels, it only matters that the Avatar Father makes Kurzweil think and feel that he has been returned to life. The equation of an avatar of the person with the person himself is an utterly repellant thing, because at its root it is the penultimate in dehumanization; and I think that on some level Kurzweil must know this, since he is trying to persuade the rubes that it really is resurrection.

Consider this justifiably oft quoted sentence from Proust’s Remembrance of Things Past:

“And as soon as I had recognized the taste of the piece of madeleine soaked in her decoction of lime-blossom which my aunt used to give me (although I did not yet know and must long postpone the discovery of why this memory made me so happy) immediately the old grey house upon the street, where her room was, rose up like a stage set to attach itself to the little pavilion opening on to the garden which had been built out behind it for my parents (the isolated segment which until that moment had been all that I could see); and with the house the town, from morning to night and in all weathers, the Square where I used to be sent before lunch, the streets along which I used to run errands, the country roads we took when it was fine.”

That is the merest sampling of what a person is. And as beautiful and evocative of the complex tangle of memory, sensation, reaction and the recursion of all those things as that passage is, even a hundred million, or a billion like it would not describe the mind of the dullest human being who moves amongst us.

Actress Marilu Henner was featured on 60 Minutes because it’s a day she’ll never forget — just like every day in her life; pas, present and future.

If you still have any doubts about the staggering volume of information, not to mention the unique wetware on which it is processed, that comprises the human mind, consider the recent scientific verification that people exist who have “superior autobiographical memory,” or hyperthymesia.[1-3] These individuals have essentially complete audiovisual recall of almost every waking moment of their lives. They can “run the movie” of their life experience forward or backward in their head and extract information from what they “re-experience.” As actress Marilu Hennner, one of those identified with this trait remarked on the CBS documentary program “60 Minutes”:”It’s like putting in a DVD and it queues up to a certain place. I’m there again, so I’m looking out from my eyes and seeing things visually as I would have that day.” These are otherwise normal individuals who have no profound cuts in normal cognitive function which might be used to explain the extraordinary storage of such memory minutiae. The “60 Minutes” segment on hyperthymesia is compelling viewing, and it is available on line: http://www.cbsnews.com/video/watch/?id=7166313n

Given the flashes of such recall most of us experience momentarily and erratically in our lives, this phenomenon begs the question: are all of us recording and storing such a broad bandwidth of information? Is it that we are not storing it, or that we cannot, and for good reason, access it with such fidelity at will? The individuals who possess this capability all describe it as burdensome and at times traumatic – memories come unbidden, constantly triggered by cues in the everyday world around them. And with some of those memories come searing emotions. If we need an evolutionary reason for the stoppering-up of such a prodigious memory in dark, amber bottles, to be dispensed only in needful draughts, these people are living examples.

Kurzweil seems to be suffering from an all too common syndrome in highly successful mavericks who have a history of repeatedly proving the experts (as well as their critics) wrong. This course through life is much the same as fame – especially if it brings fortune with it, and thus the ability to surround oneself with people who either share your worldview, or who will (or actually do) agree with any idea or obsession that takes charge. Removed from the tempering focus that reality affords most people, it becomes easy to slip into a world where the line between your dreams and desires, and what is really possible, becomes blurred and then disappears altogether. Kurzweil appears to be well on his way there, if he hasn’t reach that final destination already, and that, well, that is just pitiful.

Many of Kurzweil’s ideas are crazy – a mixture of wishful thinking, inappropriate application of animal data to humans, and in the case of his resurrection scheme, poisonous and dangerous to cryonics on at least two levels. First, it is wrong – people are not scraps of paper, or even whole heaps of them. That is a demeaning idea at best, and a dangerous one at worst, if it is taken seriously. Second, while Kurzweil still commands respect, at some point the men in the media with the butterfly nets will come calling. Kurzweil’s anti-aging program is much more likely to shorten his lifespan and deplete the pocketbook of the average person, upon whom he urges its use, than it is to provide any medical benefit.

This kind of disconnected, narcissistic spiral carried out privately is a thing that evokes pity, and even shame in seeing it. Those of us who have been involved in life extension for 20, 30, or 40 years have seen it before; increasingly desperate and delusion belief that barely suggestively beneficial molecules in animal studies will confer decades of added life, and finally, the decline into frailty and death. As I watched the “Nightline” program, I realized that there is yet another advantage to cryonics that I had not previously considered, and that is the extraordinary dignity and courage with which most cryonicists confront the end of this life cycle. While many were ridiculed for their lack of realism for a lifetime, most were men and women who did what they reasonably could to live as long as possible now, made no exaggerated or unreasonable claims about cryonics – and in fact, regarded it and represented it as what it currently is – a long shot experimental procedure that may well not work, but for them was infinitely better than the alternative.

The extraordinarily accurate, generally matter of fact, and with few exceptions dignified coverage of Bob Ettinger’s passing into cryopreservation is an example. It’s a worthy example and the way we should strive to be seen. Kurzweil reportedly has cryonics arrangements with Alcor. I’m glad to hear that, because I think he is a fundamentally a very good and very decent man who shares our core values. He has improved and enriched the lives of countless people through his scientific and technological innovations. However, as I can tell you from experience, while many disabilities are now tolerated in our society, crazy and creepy are not amongst them.

References

1.            Cahill L, McGaugh JL: Modulation of memory storage. Curr Opin Neurobiol 1996, 6(2):237-242.

2.            Cahill L, McGaugh JL: A novel demonstration of enhanced memory associated with emotional arousal. Conscious Cogn 1995, 4(4):410-421.

3.            Parker ES, Cahill L, McGaugh JL: A case of unusual autobiographical remembering. Neurocase 2006, 12(1):35-49.

 

Posted in Cryonics Philosophy, Culture & Propaganda, Gerontology | 28 Comments

Fucked.


By Mike Darwin

Have I got your attention now?

Good.

Most people say my writing here is far too long and not nearly to the point. Today I’ll remedy that. [Though you’ll still have to read this http://wp.me/p1sGcr-1h for what I going to say here to have much credibility. Read, read it carefully, and note when the contents were first published on-line.]

A couple of readers have also noted that I “seem to be in a hurry” with whatever my agenda is. Today, in part, I’ll explain why.

Over the past few days the true state of the global economy has started to be unveiled. It is going to get a lot worse. I’m no prophet or seer; would that I were. Because then, I could quantify it all for you and spoil the ending by telling you how it’s going to turn out; for you, for me, and for everyone else on the planet. But the truth is, I have no crystal ball and no metaphysical “inside track” on the future. I had hoped, fervently, that I might have some more time, that we might have some more time – perhaps as much as a year or two, before this global economic decompensation occurred. Well, no such luck. What is happening now is the beginning of what is going to be a very bad time. I have been back and forth over the skin of this earth these past 6 years, and I can tell you that much of the world has been precariously balanced on a knife’s edge of instability, fear, hopelessness and simmering rage for onto to a decade, now.

When the French Revolution arrived, Louis VI and Marie Antoinette could hardly have been more surprised. Hosni Mubarak, lying in his hospital bed in a cage Cairo, must certainly feel a similar sense of disbelief and disorientation. To be plucked from his villa at Sharm el Sheik, after he surrendered the Presidency? Incredible! The difficulty for many of you reading this (in the Developed World) is that you have lived like Louis, Marie and Hosni for the last few decades – completely out of touch with that segment of the world deemed both untouchable and insignificant. It’s not that you’ve actively avoided them, but rather than you could not even see them, and if you did catch a glimpse of them from time to time, out of the corner of your eye, you not only had no opportunity for discourse with them – you lacked the language – you literally lacked the language – both symbolic and visceral – to communicate. You might more easily have communed with an ant, or an apple tree.

Now, regrettably, many of you are about to join them. Do not worry about any lack of knowledge of their linguistics. The lingua franca of fear and disenfranchisement is one that all but the Doctor Panglosses, and the Wickens Micawbers of the world, learn with astonishing speed. Chances are, you will too.

I don’t know how much ‘play’ there is left in the system. That means I don’t know when the futile and irrational wars the West is currently prosecuting will be replaced with much larger, more costly and absolutely essential conflicts. It means I don’t know exactly when healthcare expenditures are going to decrease from 17.6% of the GDP, to somewhere in the single digits (and all the grim statistics that implies). It also means I can’t tell you exactly when the currency is going to start really inflating – in part, because I don’t know to what extent deflation from lack of demand for major commodities will occur – or when – although I note that oil prices have already dropped.

I am an expert, a bona fide expert at watching things die and observing, in order to understand the mechanics of that process, even to the point where it has proceeded well into decomposition. Human and non-human, I’ve observed so many deaths I long ago lost count. This has made me wise enough to ‘know it when I see it,’ and wiser still, to know that I lack the tools to bring precision to my understanding of the process. I can tell you when it is underway, but I cannot tell you the appointed minute, the appointed hour, or even the appointed week, month, or year of its arrival.

I said I’d keep this bearably short, and I will. We’ve been fucked. It happened quite some time ago, but in the daze of the booze and drugs, we simply didn’t feel it – until now. My message, here and now, is to first be aware that this has happened. You have no time for denial, or for recriminations. Second, neither panic nor abandon hope in the months to come. Third, immediately stop all non-essential expenditures and save everything you can. When you need to convert those savings into non-cash commodities, of one kind or another, will become apparent in due time. If you have modest and manageable debt, pay it off. If you have large debt, begin to position yourself to walk away from it with as little injury to your assets and psyche as possible. Much of the work of doing this in the US is psychological. In other places, more material preparations will likely be required. Finally, if you are a cryonicist and you want to continue to be one, be prepared to relocate. It is very likely that cryonics (biopreservation) is going to require the support of an active, cohesive and geographically united community.

I am sorry for this message. I hoped to have far more time to sieve a working group of good minds, with good hearts, to confront what is now upon us. No such luck.

Posted in Cryonics Philosophy, Culture & Propaganda, Economics, Philosophy | 62 Comments

You Bet Your Life!


Figure 1: Roulette is how almost everyone thinks of cryonics in terms of it being a gamble. The odds are what they are, they slim and they are heavily weighted in the House’s favor. In fact, nothing could be further from the truth.

 

“Life is a gamble, a game we all play,

But you need to save something for a rainy day.

Don’t put it all on the line for just one roll

You’ve got to have an ace in the hole.

No matter what you do, no matter where you go

You’ve got to have an ace in the hole.”  – George Strait, “Ace in the Hole

 

Figure 2: The only way to beat the Devil is to outsmart him and out-bluff  him – as well as have a little luck on your side.

Cryonics is often referred to as a gamble, and it is. But the real question is, “just what kind of a gamble is it, anyway?”  Most people think of gambling as ‘all of piece,’ and most don’t think much of it. That latter opinion is one held for good reasons, not the least of which are that the odds are stacked against you, and the whole business can be highly addictive, as well as financially ruinous.  But as the country crooners tell us, “life is a gamble, a game we all play.” And in this case, it’s not a game we can opt out of for something better. We may not be willing gamblers, but we are gambler nonetheless. Neither moral superiority nor the most astute negotiations will get us out the game alive; the Devil doesn’t give a damn for clever argument, or contrary principle.

Because, like it or not, are in the game, it behooves us to examine how the game is played. While there are few concessions to our possible survival, the most important of these is that not all of the games we can stake our life on are created equal. Some of the gambles we are forced to make are existential, they’re like roulette or craps; we have no control over the odds, and about all we can control is how much exposure we have (and often not even that). Getting hit by a meteorite or struck by lightning are two classic examples of existential risk. However, it’s worth noting than even in these instances, with enough time and enough knowledge, we can very likely alter the odds in our favor.

Figure 3: Not all games are created equal and not all gaming venues offer the same odds. Good judgment and skill actually allow a few people to make a very good living playing poker.

Most people who are critical of, or who feel hopeless about cryonics, make the mistake of assuming that cryonics is a fixed odds proposition, like rolling dice or dropping the ball on a spinning roulette wheel. This erroneous assumption is tied up with their mistaken perception of cryonics as a fully developed product. They think of cryonics as a discrete, consumable item, like a bag of crisps, a candy bar, or even a computer, or a radio. Or they think of lit ike an automobile maintenance contract, or an insurance policy that pays off when you need it.

It isn’t.

All of those products and services can be assigned, with a high degree of precision, a probability of how they will perform and what your likelihood is of being satisfied with them. They are fully developed products. And mostly, all you need to know about them is present, free for the asking in the culture, in the form of “common knowledge,” information from friends and family, and, of course from advertising. You pay your money and that’s it. Nobody needs to explain to you, or to anyone else, what a TV or broom or is for, how to use them, and what might go wrong with them over time.

This is no way describes cryonics.

So the first side-benefit you get by making cryonics arrangements is that you now have a proprietary interest in learning what it is that you just bought! What’s more, you will soon become aware that you need to keep learning, because cryonics is an undeveloped, immature, and above all experimental technique.  I signed up with the Cryonics Society of New York (CSNY) when I was 15 years old. CSNY is long, long gone, and I’ve been signed up with 2 other organizations that have also vanished. This kind of dynamicity is likely to continue, and it may well continue even after suspended animation is perfected; longevity in corporations is likely much more of a crapshoot than the technical feasibility of cryonics itself. So, if you can’t keep learning until old age or cardiac arrest overtakes you, you are unwilling to do so, or you are an idiot, then cryonics is definitely not for you.

Because non-cryonicists have the view of cryonics as a developed product (like an automobile or a light bulb,) they have a similarly inaccurate and warped view of the odds. The odds of the Titanic sinking with the loss of 1,517 lives were 100% on 15 April 1912. But, what if the Titanic were to have taken, say, 12, 24, or 48 hours to sink? Depending upon how the passengers and crew behaved in that interval, the number of lost lives might go way up, or way down.

There were a lot of smart people on board the Titanic – very clever and very inventive people. There were also a veritable army of craftsman and skilled laborers locked up in steerage. But they were all panicked and they had very little time to react. Given a longer interval and the willing participation of the best minds and the most able hands aboard that ship, how many people need have died, or would have died? Were there ways, other than the optimal loading of the inadequate number of lifeboats that would have saved lives? Would clothing those passengers consigned to the icy sea in multiple layers of clothing saturated in grease, shortening, or oil, attaching them to life-ropes, and rotating them in and out of the lifeboats, have saved additional lives? What kind of makeshift lifeboats or floating platforms could have been made on an expedient basis from materials on the ship, thus allowing additional passengers to remain afloat and out of the freezing water?

Figure 4: The House Edge (HE), or vigorish, is the profit the casino makes by altering the odds in its favor. The HE varies from venue to venue and sometimes from time to time in the same venue. The HE is analogous to the “negatives” your cryonics organization brings to the table.

Two examples of gambling where the odds are not fixed and where skill, as well as luck, often makes the difference between success and failure are poker and blackjack. But even there, the odds can be considerably improved if the player understands the concept of the House Edge. The House Edge (HE), or vigorish, is defined as the casino profit expressed as a percentage of the player’s original bet. (In games such as Blackjack the final bet may be several times the original bet, if the player doubles or splits.) If you look at Figure 4 you can see that the HE can vary quite a lot from casino to casino. A good way to think of the HE is to think of it in terms of the likelihood of success or failure your choice in cryonics service providers is likely to have on your overall chances of cryonics working for you (and thus of your survival).

Unfortunately, the HE isn’t posted over the door of any cryonics organization and it’s up to you, as the thoughtful gambler, to figure the HE out for yourself. That won’t be easy to do and the best way to do it is to have a strong and ongoing incentive to keep working on a solution to the problem. Being signed up is the thing that is most likely to provide the requisite proprietary interest and the necessary experience and information. After all, one of the things you are paying for by being signed up is regular updates, newsletters and other information services from your cryonics organization. Those things provide extraordinarily good feedback about the vitality and the competence of the organization you’ve chosen. And they also serve to generally educate you about cryonics.

What the public, and what all too many cryonicists need to learn about cryonics is that the odds are not fixed to those that are calculated at any given point in time, because, in large measure, you are not carting off a discrete product to screw into your lamp, to process your words, or to play your video games on. You set the odds of success or failure to an amazing degree. [You also do this as an individual, to a tiny degree for the success or failure of the company that you buy a light bulb, or a computer from.] Cryonics is thus an activist proposition. Customers can, of course, be customers – if they insist.  But in cryonics, as in any other market transaction, perfected or experimental, you get what you pay for. In the case of cryonics, the fees required for success are not even remotely reducible to cold hard cash, alone.

Figure 5: How many more would have survived if there had been 12, 24, or 48 hours to prepare instead of 2, before the Titanic sank? The odds of survival in a life or death situation are a result of the complex interplay between the time available, the physical resources, the human resources, the absence of panic and lastly, chance.

It’s a regrettable analogy, but a valid one, that we are very much like passengers aboard a slowly sinking Titanic. The Titanic was a microcosm of the very best of early 20th century technology. It was comprised of a vast range of materials and it was equipped with a maintenance shop stocked with the finest tools of the era. But most importantly, it was equipped with some of the finest technological minds of the time, as well as with many able craftsmen. Even in the time allotted, the ~2 hours between the time the time it was first understood that the ship was sinking, and the time it slipped beneath the waves, had there been order, a willingness to accept the gravitas of the situation, and full use of the minds and hands on board, the loss of life would have been a fraction of what it was.

Figure 6: We are gambling for our lives; the stakes couldn’t be any higher. Do you want to win, or lose?

Lose and we die. Draw and we stay cryopreserved and waiting, Win and we get a chance at indefinitely long life and a wild and wonderful universe to live it in!

It’s going to take all the composure, good judgment and raw intelligence we can muster to beat the House at this game.

The only question now is, “Are you in, or out?”

Posted in Cryonics Philosophy, Philosophy | 37 Comments

Science Fiction, Double Feature, 2: Part 3

Introduction & Tour of the Alcor-B Foundation’s Mobile, Arizona Patient Care Facility & Existential Colony

 Address given to Alcor-B Foundation Cryopreservation Members and Staff

Alcor-B Cryopreservation Research Foundation (ABCRF)

15 September, 2012 By Gorton Carpenter, M.D., Ph.D., President of the Alcor-B Foundation

Figure 1: The Alcors are the second, smaller and dimmer companion stars to Mizar, the bright stars that comprise the crook in the handle of the Big Dipper constellation. In the Arab world of the 5th Century CE, Mizar’s much less bright (and more difficult to see) companion stars, Alcor-A and Alcor-B were used as tests for good vision. Only someone with the clearest and most acute visions could see the Alcor’s. Alcor-B was discovered early in 2011 using Project 1640m, which makes use of the Hale Telescope’s adaptive optics system. Project 1640 gives the Hale a view almost equal to what is possible in space. The instrument also has the ability to block out the light of a star, allowing faint objects located next to a star to be seen. The Hale, armed with Project 1640, was pointed at Alcor earlier this year and found that it isn’t a single star. Alcor has a small stellar companion that hadn’t been seen before: Alcor-B, a small, dim red dwarf star about one fourth the mass of our Sun. To see Alcor-B you must have the superior vision that only mastery of the most sophisticated technology allows. Alcor-B is thus a test for the clearest and most acute vision – vision capable of seeing things as they really are – not just as they appear to be.

Figure 2: Alcor-B President, Gorton Carpenter, M.D., Ph.D.

We have covered a fair amount of ground here today, in pretty much the order we needed to, and now it is time to intellectually explore what lies below the surface here, as we are about to do physically.

The existential risks that cryonics and Alcor-B confront are well known to most of you. As you can see in this slide (Figure3), those risks have been color coded based on the risk assessment done by the Timeline to Recovery Project (TRP) analysts. Those in red were deemed the highest risk, with those in yellow coming in a close second.

Figure 3: The primary existential risks that cryonics patients and Alcor-B staff face in the coming years. Arguably, two of those risks, climate change and economic upheaval are beginning to unfold at present.

Had we remained in the greater Los Angeles area we would already be suffering from the effects of a devastating earthquake. We can congratulate ourselves for having dodged one arrow. However, there are some arrows of fortune it is hard to escape. We are already in the throes of a serious economic upheaval, indeed of a global depression, and we are also suffering from the early effects of what will very likely be a climactic catastrophe of similar magnitude to the Little Ice Age, or the MezoAmerican Drought that collapsed the civilization of the Maya. We have the technology to cool the earth, but it remains to be seen whether we have the will, as a species, or the political ability equal to the task. Unlike as was the case with the Big One, from these two existential threats we cannot run, but rather, only hope to shelter ourselves until they pass or can be overcome buy our own efforts.

Figure 4: The map above shows the probable extent of the spread of a highly infectious communicable disease in the US. By day 87 virtually all populated areas of any size are infected. The inset curve shows the rate of transmission from the start of the infection until saturation is reached at day ~ 87. There is a window of ~ 30-50 days where reverse quarantine measures may be effective, providing that the infection has not already entered our colony from contact with Phoenix, or other large metropolises.

The TRP projections show a high probability (0.07) that a consequence of the interaction of the current climactic and economic chaos will be the emergence of one or more highly infectious, and reasonably lethal, pandemic diseases. Already, the untreatable strain of N. gonorrhea, which emerged late in2010, has created major public health problems and untold misery in the Developed World. In the Third World, it has proven an unsustainable strain on the healthcare system, and has resulted in a growing population of often malnourished, and now chronically morbid individuals, who are in a weakened state and easy pretty to other infectious agents.

The emergence of carabapenem resistance in gonorrhea, the last line of defense in the treatment of this venereal disease, has broader implications, since global surveillance is increasingly detecting the plasmid that confers antibiotic resistance on this organism in other microorganisms. Given the cohabitation of N. gonorrhea with S. aureus, and the various members of the Streptococcus family that naturally colonize our skin, it is likely only a matter of time before fully antibiotic resistant strains of these organisms emerge, and we are plunged  back into the dark and terrifying time before effective antimicrobial therapy existed.

This slide (Figure 4) shows the time course and expected pattern of pandemic disease spread in the United States. We are, as you can see, located fortunately with respect to having some days notice that trouble is afoot. We have equipped the Alcor-B Facility with Nuclear, Chemical and Biological (NBC) air handling facilities, and we have added to those the ultraviolet virucidal treatment of all intake air. We have also offered subsidies and assistance to all member households on the campus of the Facility to allow them to prepare for such a contingency. And of course, a comprehensive plan of action to implement the reverse quarantine of the Facility, is also now operational. Part of the assistance offered resident members here is participation in the food reserves program which provides for sufficient long-term-storable foodstuffs to provide a sufficient calorie, protein, and micronutrient intake for 3-years, for each resident of our community.

Figure 5: Two views of the Alcor-B Patient Care Bay during the interval from the mid-1990s (left) to the early 2000s (right).

The Alcor-B patient care facilities in the 1990s (Figure 5) were woefully vulnerable to external assault – a risk we didn’t take seriously, in large measure because we thought we had no reason to. While cryonics has never been a treasured part of this culture (laughter), and while it has long been held in contempt, the contempt was never of a malicious, let alone a violent nature. We were considered non-threatening, and remained so, until the cryopreservation of the iconic American baseball hitter Ted Williams, in 2002.  At that point, an irreversible threshold was crossed.

Cryonics not only touched mainstream American culture in an ineffable way, it forced it to confront the fundamental dichotomy between its values, and ours. Not only could the culture not comprehend that one their heroes wanted to pursue practical immortality, they could not even begin to comprehend that we were not going to bend, either to their will, or their flawed system of values, and surrender an Alcor-B patient to the mob for destruction. This resulted in vandalism, gunfire into the Alcor-B facility, and the emergence of a small but damaging corps of people committed to the destruction of not only Alcor-B, but of cryonics as a whole. And not just here in the US, but in the whole of the West, as the actions of individuals in the UK and Western Europe demonstrated.

Figure 6: The Alcor-B Patient Care Bay in 2009, shortly before the move to the Mobile, AZ Facility. (Photo by Murray Ballard.)

As late as a year ago, this is how our PCB looked (Figure 6). While precautions had been taken to reinforce the perimeter walls, and to protect the ceiling/roof from assault by the use of blast-resistant polymer matting, there was no control of the facility perimeter and the degree of protection against an explosive device as simple an easy to fabricate as a large pipe bomb, was minimal. Thankfully, the titling caption on this slide is now obsolete.  We hope that the Cryonics Institute will also act to harden their facilities to protect their patients from assault by the deranged as well as by the evil and determined.

Figure 7:  A contemporary view of the patient care area of the Cryonics Institute’s facility in Clinton Township, MI

Figure 8: At left above, two of the below ground silos that housed Bigfoot dewars at the facilities of CryoSpan, Inc., in Rancho Cucamonga. CryoSpan is no longer in operation.

We considered many options before deciding upon the Mobile, Facility. One option was to protect the patients in the way that CryoSpan, Inc., did in the late 1990s (Figure 8). Mark Connaughton and Paul Wakfer did a brilliant job of implementing a suggestion from Mike Darwin, that the patient dewars be sunk in the ground in steel reinforced concrete silos. This approach provided an excellent level of protection against many of the existential risks that we’ve just covered (Figure 3). But it falls short of the comprehensive protection we wanted, and of course, it could not address protection of the staff ,or the assurance of the infrastructure required to maintain the patients in cryogenic refrigeration.

Figure 9: The relative scales of a standard, immersion LN2 storage Bigfoot dewar, and the ECD-60 dome that now houses Alcor-B’s patients.

After a great deal of searching and evaluation, we decided upon a facility close enough to a major city to make LN2, major emergency medical care, and the other amenities of civilization within easy reach, and yet be far enough away to be outside of the “ring of destruction” cities create when they implode from civil unrest, or are the target of thermonuclear attack. That’s how the Mobile site was selected. The decision was then made to use a range of Green Eye Technology modular shelter systems to fabricate the most hardened and subterranean parts of the Facility. To house the patient storage part of our operation, we selected their ECD-60 (Earthcom Dome, 60 ft diameter x 22 ft high) The ECD-60 serves as a central atrium to connect the multiple CAT 12 and CAT 25 shelter modules (Figure 10).  In addition to patient storage, the atrium is used to store additional food, houses the communications and defense center, serves as a meeting and entertainment area, exercise area, and so forth. The ECD-60 has its own NBC air supply system with a peak capability of  processing 1200 cfm of outside air. As I said previously, we have outfitted that air handling system with a UV sanitizing system. The relative size of the ECD-60 to a Bigfoot patient storage dewar is shown in this slide (Figure 9).

Figure 10: The subterranean complex that comprises the maximally hardened parts of the Alcor-B Mobile, AZ Facility. The ECD-60 Dome serves as the hub from which 11 modules radiate like spokes. There are 6 residential modules, a hospital/dental module, a laboratory module which houses an emergency cryopreservation capability, a diesel fuel storage tank, a diesel powered electricity generating plant and a greenhouse which is used for storage of supplies until the facility becomes active in an emergency.  The Patient Care Area is the in part of the ECD-60 that adjoins the clinical and technical spokes of the facility. The remainder of the ECD-60 houses the communications and defense center and is used for storage, communal dining and meeting spaces.

This slide shows the complete layout of the subterranean area of the Facility. The costing figures I will be discussing directly include only the ECD-60 Dome, one Cat-12 Residential Module and the Power Generating and Fuel Storage Modules. The other modules of the facility you see laid out here were paid for either by consortiums of Alcor-B members for their own use (via a long term lease-back agreement), or through directed donations. The Catalano Family deserves our tremendous gratitude for providing the funds for the Hospital/Dental and Laboratory modules. These facilities will not only provide medical care for staff and residents, they also allow for any member who needs to be cryopreserved to be perfused and vitrified, even under emergency “hunkered down” conditions.

This configuration, when the greenhouse is operational, will allow for the shelter of ~ 300 patients (as neuros), as well as 300 residents and staff for a period of 3 years, without recourse to outside resources.  This includes all resources necessary for survival including, food, water, medicines and NBC processed breathing air. The Patient Care Area, as currently configured, can hold 200 whole body patients and 250 neuropatients. However, in the event of an existential catastrophe of such a magnitude that neither grid power nor liquid nitrogen is available, the whole body patients would, of necessity, be converted to neuro. This could conceivably change if extra generating and liquid nitrogen production capacity were to become available.

 Figure 11: At right above, two men from the construction crew stand atop the ECD-60 shortly before the earth backfill was completed. At left above is the Patient Care Area of the facility as it appears today.

This image (Figure 11) shows the backfill operation underway (at right). The two workers standing atop the dome give some perspective to the scale of the structure and the size of the undertaking. None of these images or plans shows the vehicle access portal (VAP) or its location, for security reasons. The VAP is the way that patient storage equipment and the patients themselves are moved in and out of the facility. Because this structure had to have doors that were blast-resistant to 2o psi of overpressure, a unique design was required and a lot of very clever engineering went into making the VAP convenient to use, as well as hardened against assault.

Figure 12: The CAT-12 houses the Alcor staff and also houses a self-contained air handing and power generating facility. The CAT-12 contains enough food and water for a 90-day stay.

The CAT-12, CAT-15 Greenhouse, Power Generating Module, and the Hospital and Laboratory Modules, were all back-filled, covered and compacted before the ECD-60 was. The ECD-60 was the last structure to be buried, because it serves as the central connecting hub – the other modules had to be in place and fully wired and plumbed before ECD-60 could be buried. And since we planned to place a heavy structure atop the Residential Modules 01 and 02 (the Friendly Fortress), it was necessary to achieve a high degree of soil compaction. This took a lot of extra time and a lot of water!

Figure 13: Installation of the CAT-12 Residential Module in the Mobile, AZ facility. The inset photo shows the interior of the CAT-12 as it appears today

The CAT-12 is the smallest housing module in the facility. It was originally selected to house the Alcor-B staff, because it was both adequate, and within our very limited budget at the time.  The CAT-12 can house 10 people in reasonable comfort and it has its own independent power generating capability, galley, 60 day food supply, and air filtration system (Figures 12 & 13). Our original plan for this facility included only the CAT-12 Residential Module. When additional funds became available for an expanded shelter capability to house Alcor-B residents, we decided to leave the CAT-12 configured as originally planned, because this would allow for staff to be emplaced independent of residents (Figure 14). This might be required in situations where the risk was deemed high enough to “button up” the facility and protect the critical personnel needed to care for patients, but where the situation was not deemed urgent enough to shelter the full contingent of the community’s residents.

Figure 14: Specifications and interior layout of the CAT-12 Residential Module.

Of course, what we would really like, would be a facility that could autonomously care for Alcor-B’s patients indefinitely. That ideal facility would be nuclear fueled, and use a super-efficient thermopile (thermocouple) generator to make electricity from heat; and then use the electricity to cool the interior of the dewars to -150C, using the Peltier effect (again, thermocouples as used in the power generating thermopile (but run in “reverse” as thermoelectric cooling elements).

Figure 15: In the event of a prolonged existential crisis the current emergency survival plan calls for conversion of all whole body patients to neuro so that everyone can be cared for within 1 or 2 ITS Bigfoot units.

This would comprise a power generating and refrigerating system with no moving parts and with a life span that would equal that of the working life of the nuclear fuel. Alas, the Nuclear Regulatory Commission is not going to give us either plutonium or Strontium-90, and in any event, thermoelectric cooling technology is not quite good enough yet!

The next best thing was to come up with a system which would run as long as currently available and affordable technology would allow, and that was within our budget of ~ $2.5 million 2010 US dollars.

Due to budget constraints, it became immediately apparent that it would not be possible to operate more than two Bigfoot units continuously in an “off-grid” fashion. The solution would be to configure our long-duration emergency capability around the conversion of the whole body patients to neuro. This would allow us to easily store 200+ neuropatients using our existing packaging and packing configurations, as well our existing cryogenic storage hardware.

The person who should be credited with first coming up with this idea of using a Bigfoot dewar to store the whole patient population, and to refrigerate it independent of the grid, was Dr. Greg Fahy. Back in the late 1980s he proposed using a liquid helium refrigerated “cold finger,” of the type used to pinch hit for LN2 in electron microscopes and other kinds of laboratory equipment that need ultra-low temperatures but don’t want to be bothered with the logistic headaches associated with LN2. His calculations at that time showed that this was indeed doable with off the shelf equipment then commercially available. So, when we began to explore this option, cold fingers were the first thing we looked at. However, we soon discovered that technological advances in small capacity LN2 production plants made the cold finger option no longer attractive.

Figure 16: The CryoMech LNP-40 liquid nitrogen (LN2) plant.

Due to advances in molecular sieving technology, as well as in the design of the Joule-Thompson helium refrigerators used to cool nitrogen (or air) to the point of liquefication, it was now possible to produce LN2 economically, and in quantity, without the need for a separation tower (Figure 16). In the past, LN2 was made by first liquefying air, and then separating out the various chemical components that make it up; oxygen, water, carbon dioxide, the noble gases, and so on… This was an inefficient process and one that required a lot of maintenance of the liquefaction equipment. It also greatly shortened the time to failure of the LN2 plant.

It is now possible to separate nitrogen from the rest of the gaseous components of air using spiral wound membranes that allow nitrogen to pass across them, but which reject the unwanted gases – very much like reverse osmosis membranes. This technology eliminates the needs for a separation tower and it greatly increases the energy efficiency of the LN2 production. The absence of water (ice) also prolongs the life of the moving parts in the system, increasing the time to failure (or preventive maintenance) by about two orders of magnitude over the small capacity plants that were available in the 1980s, when Alcor-B first examined this technology.

 Figure 17: Specifications of the CryoMech LN2 plant.

The platform we selected for use here in the Mobile Facility was the Cryo-Mech, Inc., LNP-40. This small LN2 production plant can generate up to 40 liters per day of LN2 at a rate of ~1.6 liters per hour. This would be enough to keep one of the Intermediate Temperature Storage (ITS) Bigfoot dewars operational and two of the conventional immersion LN2 storage units in operation.

Figure 18: The elements which comprise the LNP-40 LN2 plant: molecular sieve membranes (upper left), air compressor which supplies air to nitrogen sieving membranes (middle right), LN2 collection and discharge dewar (center) and the Joule-Thompson nitrogen liquefier (lower left).

Necessarily, two of these plants must be purchased at the same time to provide redundancy, both during routine servicing and in the event one of the plants experiences an irreparable failure during the off grid interval. Thus, our initial capital outlay for the complete refrigerating system, including two LNP-40 LN2 liquefiers was ~ $144,000.  We purchased enough service kits to allow for continuous operation of both systems for 3 years.

Figure 19: Additional specifications of the CryoMech LNP-40.

The LNP-40 discharges LN2 into a specially designed 160 liter storage vessel from which it is subsequently dispensed to the Bigfoot units, as needed. In the near future we plan to have the LN2 from the LNP-40 collected in a larger, super-high efficiency storage vessel. This will maximize our energy efficiency, minimize the wear and tear on the liquefier, and allow us to better use the LN2 produced as “energy currency” for refrigeration where and when needed elsewhere in the Facility. As you can see (Figure 19) LN2 production does not come cheap in terms of the energy required. While industrial-scale plants are much more efficient, the LNP-40 is still impressively parsimonious when it comes it come to power consumption, since it uses only 5.5 kW.

And that leads to the next issue we had to address, namely where are we going to get that kind of power from off the grid, and reliably, for up to 3 years at a time? Diesel fuel is an option, but the quantities required are not only costly, they presented major regulatory problems with both Maricopa County, and the City of Goodyear. We took a long hard look at solar, and decided it was not only workable, but that it was the superior option. Besides, it seemed only fair that, given the merciless baking we endure from the Arizona sun, year in and year out, that we be able to convert some of that blistering energy into refrigeration for our patients!

Figure 20: The key elements (and their cost) of Mobile Facility’s solar power system.

We were pleasantly surprised to find that there were systems available pretty much as turnkey items in the capacity range we needed, principally 150 kW (Figure 20). We have two discrete solar power generating arrays: one atop the Friendly Fortress (FF, surface terminator) to the facility, and another, much larger one, located south of the FF. We have plans to enclose this second array in a more secure fashion, since it is essential to provide sufficient power to operating the LNP-40. The array atop the FF provides enough power for the staff and residents. We also have a large (buried) reserve of stabilized diesel fuel which is sufficient to operate the entire facility continuously for 3 months. Used in conjunction with solar power, this reserve of diesel will allow for uninterrupted operation for approximately 3 years. This assumes the normal number of sunny and cloudy days here in the Northeastern Sonoran Desert. All bets are off there is a nuclear winter, or other diminution of the anticipated solar radiation, of any duration.

 Figure 21: Supercapacitors of the kind used to store solar-generated electricity in the Alcor-B Facility to meet the “surge demand” of starting motors.

At the present, we have 17,442 square feet of solar electric panels. While we are relying on lead-acid batteries to store energy, we are also using Supercapacitors. Unlike batteries, which store energy in an electrolytic chemical reaction, supercapacitors store energy in the field state across the area of an electrode, which is made of a sophisticated carbon aerogel. Supercaps offer a combination of high power storage density, high voltage levels, and high charging speeds. This means much more compact and powerful storage that can be quickly recharged. For this marvelous innovation we thank Eugen Leitl, who first suggested their use, and who was of great help in generating the specifications and working the Canadian manufacturer, to ensure that the finished product met our needs. Supercaps have vastly longer life spans than lead-acid (or other kinds of) batteries. But their greatest advantage is in their unique ability to meet the large surge requirements of the motors in use throughout the facility, and especially the air compressor and the Joule-Thompson compressor motors necessary to operate the LNP-40. Supercaps quickly discharge the large amounts of energy required for the “start-up surge” of these motors

Figure 22:  The cost breakdown and key elements of the patient care essential portions of the Alcor-B Mobile, AZ Facility (2010 US dollars).

In concluding, I’d like to briefly review the key elements of this beautiful new facility, before we start our tour of it. The entire physical plant, including LN2 production, can be operated from the 150 kW solar arrays and is capable of running for up to 3 years without grid power, or supplies from the outside. The total cost to Alcor-B for the patient and staff essential parts of this facility was $2, 247,750 in 2010 dollars. The cost for the rest of the facility, exclusive of the above ground residences, was $4, 356, 925 in 2010 dollars. I believe I can confidently state that this is the most secure, the most technologically advanced and the most beautiful cryonics facility on the plane! It fulfills the dream of our founders, Fred and Linda Chamberlain, and of Mike Darwin and Jerry Leaf – all of whom realized, and worked for the day when Alcor-B would be as protected from existential and other risks, as current technology allows. Today, their dream is our reality.

The End of The Beginning

 

Posted in Cryonics Biography, Cryonics History, Cryonics Philosophy, Cryonics Technology (General), Culture & Propaganda, Economics | Leave a comment

Science Fiction, Double Feature, 2: Part 2

Introduction & Tour of the Alcor-B Foundation’s Mobile, Arizona Patient Care Facility & Existential Colony

 Address given to Alcor-B Foundation Cryopreservation Members and Staff

15 September, 2012

By Gorton Carpenter, M.D., Ph.D., President of the Alcor-B Foundation

Alcor-B Cryopreservation Research Foundation (ABCRF)

Figure 1: The Alcors are the second, smaller and dimmer companion stars to Mizar, the bright stars that comprise the crook in the handle of the Big Dipper constellation. In the Arab world of the 5th Century CE, Mizar’s much less bright (and more difficult to see) companion stars, Alcor-A and Alcor-B were used as tests for good vision. Only someone with the clearest and most acute visions could see the Alcor’s. Alcor-B was discovered early in 2011 using Project 1640m, which makes use of the Hale Telescope’s adaptive optics system. Project 1640 gives the Hale a view almost equal to what is possible in space. The instrument also has the ability to block out the light of a star, allowing faint objects located next to a star to be seen. The Hale, armed with Project 1640, was pointed at Alcor earlier this year and found that it isn’t a single star. Alcor has a small stellar companion that hadn’t been seen before: Alcor-B, a small, dim red dwarf star about one fourth the mass of our Sun. To see Alcor-B you must have the superior vision that only mastery of the most sophisticated technology allows. Alcor-B is thus a test for the clearest and most acute vision – vision capable of seeing things as they really are – not just as they appear to be.

Figure 2: Alcor-B President, Gorton Carpenter, M.D., Ph.D.

Why?

Now that we’ve returned from the break, hopefully refreshed and ready for a bit more technical material, I’d like to continue by explaining why we undertook to create the Mobile, AZ facility. In hindsight it seems strange that those who started cryonics were not more concerned with what could go wrong, let alone what the probability was of those things actually going wrong! Looking back at the press clippings and the media coverage from that era, it is for sure that the public had no problem identifying possible problems with cryonics.

While the average Joe may have been focused on power failures, economic calamities, nuclear war, and overpopulation as obstacles in simple-minded ways that irritated cryonicists, and caused a knee jerk reaction in them that led them to dismiss these objections. Their objections were, nevertheless, real and valid. No, our patients aren’t refrigerated by compressors that depend upon a continuous supply of electricity. But they are refrigerated by liquid nitrogen which is dependent upon the power grid– any lasting disruption to the power supply, or even rationing of electricity or, the energy commodities it is produced from – and cryonics patients warm up and rot. The difference in the outcome from the objection raised by Average Joe is only 30, or 60, or 90 days, at most. The standard response of cryonicists then, and mostly now, has been, “Cryonics facilities don’t use electricity to refrigerate cryonics patients: they use liquid nitrogen (LN2). ”

And how is Ln2 made? With electricity, of course.

And while cryonicists were quick to point out (and to take delight in) the inaccurate and foolish predictions of Malthusian doom by the “experts,” such Paul Erlich. [1] It was to no small degree because of unprecedented and unforeseen technological advances in agriculture, food distribution (computerization) and food preservation technology that that this catastrophe was avoided. What those cryonicists did not do, was to the question the wisdom of courting catastrophe, absent at least a reasonably good assurance that the solutions would, in fact, be there when they were needed.

Facing Limits & Preparing For Adverse Consequences

And of course, our contempt for this issue begged the question, “Just what are the limits to population growth, even given the most optimistic projections for the growth in food supply?” Also not considered were the geopolitical and social issues that attend disproportionate growth in the populations of some peoples, while that of others remains unchanged. Nor was there any consideration given to the social-demographic effects on populations where the majority of the citizens are in their 20s, are unemployed, are poorly educated (or not educated at all) are impoverished, and are facing a future largely devoid of hope. It is also certain that we did not consider the consequences of even a single hiccup in the food supply, such as a sustained and widespread drought, that would double or treble food prices in those same already marginally fed populations.  Something that is happening right now. The result was that to an alarming extent we did not see the mass famines that now engulf much of Sub-Saharan Africa and significant parts of India. And it is certainly the case that that our predecessor cryonicists did not foresee a time when over 16% of Americans would be receiving Food Stamps (Figure 3), and that people using EBT [1] cards at the till in a grocery store would become something that everyone recognized, and that almost no one held in contempt – for fear they might find themselves with one hand in a few short months.

Figure 3: In the closing days of 2012the percentage of Americans receiving Federal Food Stamp assistance reached 16.25% of the population, up from 14.2% in June of 2011.[2] The continued deterioration of the US and the global economy coupled with major agricultural failures in the US as a result of drought and record summer heat throughout most of the nation are the factors most immediately responsible for this situation.

Of course, this situation did not materialize out of thin air, nor did it happen overnight. We did not suddenly awake to over a quarter of this nation’s children being on Federal food assistance, with more than half of the children in Alabama and Missisippi needing Food Stamps, just to stay fed.

Figure 4: The US median household income has been flat or in decline since 1999. Since 2007 the decline has been precipitous and sustained and this is consistent not with an economic recession, but rather with an economic depression.

TRP’s (Timeline to Rescue Project’s) comprehensive econometric analyses had long shown the indicators that this economic upheaval was coming. Median US household income has been either flat, or steadily declining, since 1999, and even more alarmingly, debt as a percentage of personal income has been rising steadily and dramatically since at least 1985 while savings as percentage of personal income have been declining over the same time period even more dramatically (Figures 5 & 6).

Figure 5: Debt as a percentage of personal disposable (i.e., non-confiscated) income.

Figure 6: Personal savings as a percentage of disposable income from 1985 to 2005.

These trends might have been tolerable over a longer time course if it had not been for the fact that the same kind of fiscal irresponsibility was being practiced on the macroeconomic scale, as well. As is evident in this TRP data from 2008, the stock market began to exhibit unequivocally bubble-like behavior in the opening years of the 1990s and this behavior, as indicated by an absolutely astronomical (and unprecedented) disconnect between real value and the “market value,” as indicated by the S&P Price Index continued until 2007 (Figure 7). The problem with bubbles, economic and otherwise, is that thy burst, and that is precisely what happened to the global economic bubble in 2007.

Figure 7: The incredible disconnect between price, earnings, dividends and probable real value of shares; and of economic wealth as a whole. Data analysis and projection by TRP.

This single piece of econometric data was grounds for us to initiate the Mobile, AZ, Project. However, any uncertainty we had was further reduced when we examined the really long-term trend in the purchasing power of the US dollar (Figure 8) and compared that with foreign borrowing, and the global debt to equity ratio. When the TRP predicted sharp and steady rise in gold prices began, we knew we had to act.

Figure 8: Purchasing power of the US dollar from 1900 to 2000.

The decline in the value dollar has been so steady and unrelieved that it was impossible for either TRP or for Alcor-B management, to envision a scenario in which this trend would not only reverse itself, but be sufficiently large to allow for any reasonable possibility of servicing what was then $6 trillion in debt. A quick look at this slide (Figure 9) shows the hopelessness of this situation once the exponential phase of indebtedness and interest is reached; something that clearly happened around 2008.

Figure 9: The US National debt as of 2010, the last year that the TRP econometricians were certain that valid data was being released by the US Treasury Department.

In 2008, these data, taken together, led TRP to recommend that the Patient Care Trust (PCT) increase the fraction of its assets in gold from 10% to 20% and that they restructure their real estate and securities holdings. This advice was taken, and what’s more, the PCT decided to commit half the capital accumulated from the 10% Rule to gold. That was $1.9 million in 2008 Dollars. That purchase was made in February of ’08 at a price of $865 per ounce. Half of that “investment” was liquefied on 02 August, 2011 at the peak of the uncertainty as to whether or not Congress would increase the National Debt Ceiling, at a price of $1,648 per ounce. This resulted in a net increase in working capital of $1.85 million 2010 dollars (after transaction-related expenses). In other words, the time and effort invested in TRP covered three-quarters of the cost of the Mobile Facility, including the cost of the land (150 acres x $650 acre). To paraphrase the father of cryonics, Robert Ettinger, in another context; economic depressions are only for the unprepared and the unimaginative. (Laughter)

The Final Fallback Plan

Figure 10: The analogy of cryonics as a bridge to the future, our future, implies that we must both build with enough safety factor to prevent collapse and anticipate existential crises that pose a genuine threat to its workability

However, we shouldn’t be even a little smug. The current situation has the potential to deteriorate into a nightmare scenario – one that all the foresight in the world cannot prepare us for – at least not given our small size, and even smaller resources.  While cryonics is our technological bridge to the future, it is, admittedly, a fragile one. And so one of the things I want to tell you about is the beginning of our implementation of our Final Fallback Position (FFP).

We have pursued cryopreservation as our method of bio-preservation for many reasons. For one thing, it was how the idea was handed to us by Ettinger and Cooper, the two men who first conceived of cryonics. They in turn were persuaded that cryopreservation was the best approach by virtue of the fact that many living systems can survive cooling to cryogenic temperatures if treated properly. And, perhaps just as importantly, both men were, understandably, hostages to the Arrhenius Equation, which states that the rate of chemical reaction is an invariable function of temperature. There’s a caveat to that though, and that is that the Arrhenius Equation only applies to systems that have molecular mobility, or in other words, to systems that are in a liquid or gaseous state. This caveat really didn’t become apparent until the era of vitrification began in cryonics in 2000. At that time, it began to sink in that systems in the solid state pretty much get a pass on the Arrhenius Equation, and it was the Arrhenius equation which had consigned stable, indefinite biopreservation to the realm of LN2 temperature, or below.

Figure 11: Culicidae: Dipter in Dominican amber ~40 million years old.[3]

While it had been known since the 18th century that biological material trapped in amber was remarkably preserved, even over time periods of millions of years. However, the quality of that preservation, and the implications for cryonics, were only fully appreciated a decade ago, with the demonstration of well preserved ultrastructure in some organisms preserved in amber. [4] And even more surprisingly, it has bow been verified that intact and relatively un-fragmented DNA is also present in some archaeo-amber samples. [5-7] There is also growing evidence that viable microorganisms may be cultured from amber ~20-45 million years old [8] and, incredibly, from aqueous inclusion in salt deposits that are at least 100 million years old. [6, 9-12] These findings led to the initiation of what was initially called the Brain Plastination Project, led by Dr. Ken Hayworth, which has since been rechristened the Ambient Temperature Vitrification Project (ATVP). The goal of the ATVP was to develop minimally biochemically disruptive techniques for rendering biological tissues into the solid state – and hence biochemically quiescent. The idea was to avoid the many chemical and biophysical changes induced by fixation by skipping this step, and introducing plasticizing monomers into tissue that was in a viable, or near viable state at the start of the procedure.

Figure 12: Buthidae: Scorpiones In Dominican Amber ~25-40 million years old.[3]

Figure 13: Cypress Plant Cell Ultra-structure: Baltic Amber ~45 million years old: http://rspb.royalsocietypublishing.org/content/272/1559/121.full.pdf and http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1634957/pdf/rspb20042939.pdf  [4]

This work is still in its infancy, but we have nevertheless learned a great deal, some of which is directly applicable to the development of the FFP. One of most difficult problems to be overcome when applying this technique to a whole organ the size of a human brain is, how do you keep the circulatory system accessible to allow for the replacement of the water in the tissue with the monomer that will subsequently be polymerized into a solid plastic, and to remove the truly enormous amount of heat liberated by the exothermic polymerization reaction?

Figure 14: A corrosion cast of the circulatory system of the human brain. The extensive vascularization of the brain allows for use of the circulatory system as both a mass and heat exchanger. Gas perfusion of the circulatory system prior to cooling to vitrification temperatures leave it accessible during cryogenic storage should fixation and plastination become necessary as a fallback position to cryopreservation.

This slide (Figure 14) shows the circulatory system of a human brain. This is the real deal, not a model. What you are looking at is something called a “corrosion cast.” In this case, the arterial circulation of a human brain was injected with a red-tinted plastic material and the brain was then immersed in a strong base, such as a concentrated solution of sodium hydroxide. The base dissolves or corrodes the tissue away, leaving behind the red plastic framework of the arterial circulation. It’s easy to see that the human brain is a “strongly circulated” organ – in fact, the brain normally received 1/3rd of the resting cardiac output – about 1.5 liters of blood per minute. The FFP researchers decided that the best way to achieve both heat and mass exchange was to keep the brain’s circulatory open and accessible throughout the procedure. In order to achieve this during solidification of the brain, they turned to gas perfusion – replacing the liquid in the circulatory system with gas.

One of the investigators (Mike Darwin) realized that if the circulatory system of human cryonics patients was similarly perfused with gas during cooling to vitrification, not only would cooling be hastened, thus reducing the risk of freezing, but the circulatory system of the patient would remain accessible, even during storage at -150C.  What this meant was that it would thus be theoretically possible fix and plastinate cryonics patients in the event that cryopreservation was no longer possible.

In this scenario, a patient would be removed from storage to a special apparatus, the Final Fallback Position System (FFPS), where his arterial circulation would be connected to a recirculating system of solvent chilled to -100C. This solvent would be pumped through the patient and would begin dissolving the viscous cryoprotectant-water solution in the patient’s tissues. The solvent would also contain fixative – initially formaldehyde to fix the proteins and, finally, a highly reactive metal, osmium tetroxide, that is necessary to fix the lipids; which comprise both the cellular and the intracellular membranes. Once the patient had been “solvent substituted” and fixed in this fashion, it would then be possible to safely warm him up to room temperature and introduce the monomer required for plastination. In fact, if necessary, this could be done by immersion, rather by perfusion (though this would necessitate removal of the brain from the head).

Figure 15: The head of a fresh  (~1.5 hrs post-mortem) human cadaver subjected to vitrification and then deep subzero fixation and plastination with Epon epoxy resin using the FFPS. Accelerated aging tests show both ultrastructural and molecular stability in the range of 1.5 to 2.0 million years.

What you see here (Figure 15) is a human head that has been subjected to this procedure following vitrification. It has taken hundreds of experiments with animals, and over a dozen experiments with human cadavers to develop this process to the point that it is ready for application to cryonics patients, should the need arise. As a result of a directed donation of $850,000, we have developed the system you see here (Figure 16). This system is capable of processing up to 8 neuropatients at one time. And yes, if you are whole body and the FFP needs to be implemented, you will be processed as a neuropatient, with no ifs ands or buts. Tthe urgency of such a situation will necessarily strain our capability perilously close to the breaking point, even with our current population of 122 patients.

Figure 16: The Final Fallback Position System (FFPS) for the automated processing of cryopatient cephalons from the deep subzero state, to ambient temperature fixation and solidification (plastination).

I want to be clear that ultrastructural studies conducted during the development of the FFPS do show considerable additional distortion of cellular architecture. The best results are obtained when the procedure is carried out without the intermediate step of vitrification. And yes, we are giving consideration to offering this procedure as an alternative to cryopreservation.  However, that is a topic for another time. For now, I felt it was important that you be fully informed not only that we have contingency plans in  place for the care of the patients in the event that cryogenic refrigeration becomes unavailable, but also that we now believe such a contingency has sufficient probability to warrant the considerable time and expense involved in developing and deploying this system.

You will be able to see the FFPS during the tour later today. For now, I think we should take our second break before lunch. Following lunch we will assemble here for the formal tour of the facilities.

End of Part 2

Footnotes

[1] EBT cards are Electronic Benefits Transfer cards which have almost exclusively replaced paper food stamps. They are similar to ATM cards but bear the distinctive marking of the state that issues them.

References

1.            Erlich P: The Population Bomb: Buccaneer Books; 1996.

2.            Bloch M, DeParle, J, Ericson, M, Gebeloff, R. : Food Stamp Usage Across the Country:http: //www.nytimes.com/interactive/2009/11/28/us/20091128-foodstamps.html. New York Times 2011.

3.            R. PGaP: The Quest For Life in Amber. Reading, MA: Addison-Wesley; 1994.

4.            Koller B, Schmitt, JM,Tischendorf, G.: Cellular fine structures and histochemical reactions in the tissue of a cypress twig preserved in Baltic amber: http://rspb.royalsocietypublishing.org/content/272/1559/121.full.pdf. Proc R Soc 2005, B  272:121-126.

5.            Schmidt A, Schäfer, U.: Leptotrichites resinatus New Genus and Species: A Fossil Sheathed Bacterium in Alpine Cretaceous Amber. Journal of Paleontology 2005, 79(1):175-184.

6.            Ascaso C, Wierzchos, J, Speranza, M, Gutiérrez , JC, González, AM et al.: Fossil Protists and Fungi in Amber and Rock Substrates:http: //digital.csic.es/bitstream/10261/33738/1/DEFINITIVOMicropaleontology_2005.pdf. Micropaleontology 2005, 51(1):59-72.

7.            Lambert L, Cox, T, Mitchell, K, Rossello-Mora, RA, Del Cueto, C, Dodge, DE, Orkand, P, Cano, RJ.: Staphylococcus succinus sp. nov., isolated from Dominican amber. Int J Syst Bacteriol 1998, 48(Pt 2):511-518.

8.            Cano R, Borucki, MK.: Revival and identification of bacterial spores in 25- to 40-million-year-old Dominican amber. Science 1995, 268 (5213):1060-1064.

9.            Stan-Lotter H, Terry McGenity, J, et al.,: Very similar strains of Halococcus salifodinae are found in geographically separated Permo-Triassic salt deposits. Microbiology 1999), 145:3565-3574.

10.          Grant W, Gemmell, RT, McGenity, TJ.: Halobacteria: the evidence for longevity. Extremophiles 1998, 2(3):279-287.

11.          Vreeland R, Piselli, AF, Jr, McDonnough, S, Meyers, Ss.: Distribution and diversity of halophilic bacteria in a subsurface salt formation. Extremophiles 1998, 2(3):321-331.

12.          Brown M: Molecular History Research Center: http://wwwmhrcnet/ancientDNAhtm

 

Posted in Cryonics History, Cryonics Philosophy, Cryonics Technology (General), Culture & Propaganda, Economics | 3 Comments